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Objective: Communication of information plays a central role in genetic counseling. There have 
been few direct comparisons of differing communication approaches. This research study 
aimed to experimentally manipulate communication of genetic information and to describe how 
the complexity of counselor communication impacts client affective and cognitive outcomes 
using a hypothetical cancer genetic counseling scenario. 
Methods: The study used a mixed methods experimental design consisting of a web-based 
module that simulated specific educational and communication aspects of a cancer genetic 
counseling session. Female study participants (N=286) were randomly assigned to watch one of 
three simulated video genetic counselor sessions of either high, medium, or low communication 
complexity consisting of 8-21 minute of short video clips. Demographic information, personal 
perceived cancer risk, genetic literacy, and patient-provider orientation were collected before 
beginning the videos, and survey instruments were administered after the videos to capture 
decisional, affective, and cognitive outcomes. 
Results: Low complexity communication of information reduced feelings of negative emotion 
(including confusion) compared to the high complexity group. Individuals in the medium 
complexity group felt more decisional conflict than the high complexity group. No other main 
effects on measured genetic counseling outcomes were detected. Genetic literacy and patient-
provider orientation had modifying effects on the relationship between complexity level and some 
outcomes. Personal characteristics, including age, race, perceived personal risk of cancer, 
genetic literacy, and patient-provider orientation were associated with some genetic 
counseling outcomes. Participants generally found the experience to be realistic.  
Conclusions: Low complexity communication did not elicit poorer outcomes than high 
complexity communication overall. Our findings also support the notion that personal factors 
influence clients’ reactions to genetic counseling communication. In accordance with principles 
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In the genetic counseling setting, patients are counseled about the biomedical and 
psychosocial implications of genetic conditions. Though “education about inheritance, 
testing, management, prevention, resources and research” is included in the National 
Society of Genetic Counselor’s professional definition of genetic counseling, the effects 
of communication of information on patients have not been well studied (Resta et al., 
2006). Additionally, what goes on in a genetic counseling session has been described as 
“a black box,” and much of genetic counseling practice remains largely unknown, though 
research using audio and video recordings of genetic counseling sessions has shed light 
on the typical content of routine genetic counseling sessions (Biesecker and Peters, 2001; 
Roter et al., 2006). These studies have suggested that genetic counselors talk more than 
their clients, and the majority of genetic counseling sessions focus on teaching and 
biomedical information (Meiser et al., 2008; Roter et al., 2006). In genetic counseling, 
complex information is communicated regarding inheritance, genetics, testing 
technologies, test results, treatment, screening, medical management, and psychosocial 
implications of a risk of a disease. Genetic counseling is not only information laden, but 
information may be provided in a way that is too complex for some clients to understand 
(Roter et al., 2007). Clearly, communication of information is critical to genetic 
counseling; Hsia goes as far as to suggest that, compared to other medical contexts, 
“information giving [is] the treatment itself” in genetic health care (Hsia, 1979). Given 
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Despite communication of information accounting for the majority of time spent 
in genetic counseling sessions, not much is known about how the way information is 
communicated impacts how patients feel and think or how it impacts their decisions. 
Specifically, there have been no tightly controlled experiments designed to examine the 
effects of providing genetic counseling-related information by altering communication 
complexity. This study has aimed to experimentally examine participants’ responses 
across varying levels of communication complexity in a hypothetical simulated cancer 
genetic counseling setting. The purpose of the study was to better understand how 
communication of information affects genetic counseling patients’ affective and 
cognitive outcomes, to examine how personal characteristics interact with 
communication complexity to affect affective and cognitive outcomes, and to gather 
exploratory data about the personal experience of receiving complex information in 
genetic counseling.  
 
Communication Models and Barriers to Effective Communication in Genetics 
 Communication of information from provider (i.e., genetic counselor) to patient is 
the central interest of our study. One model of communication of information is the 
information-giving model of care, which proposes that the communication of the 
information is the provider's job, and the decision-making task is the patient’s 
responsibility (Redsell and Buck, 2009). Redsell and Buck emphasize that the 
“information giving model... assumes that information is understood by everyone in the 
same manner,” and that it is based on “a view that people make conscious, rational 
choices about health behaviors and that factual information alone will influence choices,” 
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(Redsell and Buck, 2009). However, not much is known about how much information is 
needed in order to be “complete” or what specific pieces of knowledge are crucial for any 
given person’s decisions. Moreover, patient informational needs and information-seeking 
behaviors differ between individuals (Schmidlen et al., 2014; Waters et al., 2016).  
In contrast to the information giving model, the patient-centered care model 
focuses on the personal informational and psychological needs of the individual patient. 
Patient-centered information provision focuses on making information accessible to 
patients and includes elements of information chunking, interactivity, plain language and 
lower oral literacy demand, and empathic statements (Windover et al., 2014; Street et al., 
2009; Doak et al., 1996; Roter et al., 2007). Genetics information is complex and often 
new to patients. Optimal learning necessitates attention to how information is presented 
and how clients engage with the information. Accessibility of information is another 
component of patient-centered care, and patients with lower health and genetic literacy 
will have a more difficult time accessing information than those with higher literacy 
levels. Additionally, genetics jargon can be a barrier for patients to comprehend the 
utility of what they are learning. For instance, patients may confuse a biologically 
functional protein and dietary protein and their relationship to genetics and health 
(Bernhardt, 2016). One study by Lerman and colleagues found that 49.5% of their cohort 
of cancer patients left the session feeling confused and feeling that they had difficulty 
understanding the information (Lerman et al., 1993). To elucidate approaches to 
remedying problems with accessibility, patient educational research has shown that 
information is more accessible when presented in chunks and when engagement with the 
information is encouraged (Windover et al., 2014; Doak et al., 1996). The patient-
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centered care and communication model allows for flexibility in tailoring information-
giving to each particular patient to meet his or her learning needs.  
There is evidence of a mismatch between the informational needs of at least some 
patients and the informational goals of genetic counselors. One study done in cancer risk 
counseling with underserved patients at a large healthcare system in California found that 
ineffective communication stemmed from a number of factors including: “(1) too much 
information; (2) complex terminology and conceptually difficult presentation of 
information; (3) information perceived as not relevant by the patient; (4) unintentional 
inhibition of patient engagement and question- asking; (5) vague discussions of screening 
and prevention recommendations” (Joseph et al., 2017). This study and others highlight 
the need for evidenced-based strategies for communication of information in genetic 
counseling, with a particular need to better understand the roles of language complexity, 
interactivity, and learning-enhancing communication strategies (Vogel, Leonhart, and 
Helmes, 2009; Roberts et al., 1994; Takayama, Yamazaki, and Katsumata, 2001; Wang et 
al., 2005).  
 
Genetic Counseling Communication 
Many health care settings, including the genetic counseling setting, involve 
provider-led communication and information giving. One study aimed to examine aspects 
of genetic counseling communication and interaction to capture “typical” genetic 
counseling in practice. By using standardized simulated clients, the Genetic Counseling 
Video Project (GCVP) videotaped genetic counselors providing genetic counseling in 
both hypothetical prenatal and cancer settings. Data from the GCVP and from other audio 
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recording studies, as well as from systematic reviews of research of the content and 
process of genetic counseling communication have found that genetic counselors are 
verbally dominant, talking three times as much as their clients (Meiser et al., 2008; Paul 
et al., 2015; Roter et al., 2006). Genetic counselors are largely in control of the session, 
and their communication style has been suggested to have a larger impact on the session 
communication than individual patient characteristics (Pieterse et al., 2005; Ellington et 
al., 2005).  
Within the genetic counseling session, the GCVP found that largest category of 
talk (56% of all talk) was spent on information provision, with almost 85% of that talk 
falling into the biomedical rather than the psychosocial domain (Roter et al,2006). This 
aligns with other research that suggests that biomedical, rather than psychosocial 
information is the focus of most genetic counseling sessions (Roter et al., 2006; Roter et 
al., 2008; Paul et al., 2015).  
The GCVP study also found that sessions with a higher proportion of technical 
terms or jargon had lower interactivity with the client (Roter et al., 2007). Interestingly, 
the self-ratings of genetic counselors’ informativeness were found to be inversely related 
to their use of medical jargon (Roter et al., 2007). Genetics providers are responsible for 
how much information is given and in what way it is delivered (Paul et al., 2015), but the 
“standard of care” communication also likely differs from specialty to specialty, as 
undiagnosed disease counseling requires different educational and informational content 
compared to a more common disease context such as breast cancer. Additionally, 
communication may depend on the institutional setting and characteristics of the 
individual counselor.   
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Genetic Counseling for Hereditary Cancer Syndromes 
In the US, according to the Centers for Disease Control, cancer is the second 
leading cause of mortality (behind heart disease), and close to 600,00 people die each 
year die from cancer (CDC, 2014). Between one in two and one in three women will get 
cancer in their lifetime, and of all forms of cancer, 5-10% are considered to be strongly 
hereditary (Schneider, 2012). Technological and scientific advancements in testing 
methodologies and understanding of cancer-associated genetic variants, as well as public 
awareness of genetic implications in cancer continue to expand the field of cancer genetic 
counseling. As of 2016, cancer genetic counseling has grown to be the most common 
genetic counseling specialty in the US, accounting for 48% of the genetic counselors that 
see patients (NSGC, 2016). This represents a dramatic increase from just 29% in 2014 
(NSGC, 2016).  
Pre-test cancer genetic counseling sessions may include discussion of the genetics 
of breast cancer, inheritance patterns, surgical decisions, screening recommendations and 
risks for multiple types of cancers associated with specific cancer predisposition genes 
(Berliner et al., 2013). As the science advances, genetic counselors must consider how to 
adapt the depth and breadth of information presented, and one recent mixed-methods 
survey study suggests that counselors are “spending more time counseling about 
uncertainty” as testing options and the likelihood of uncertain results increase (Hooker et 
al., 2017). The relatively high prevalence and thus high awareness of cancer support the 
feasibility of a broad range of research designs, including hypothetical designs to 
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Genetic Counseling Outcomes 
 While there is a lack of agreement about the most appropriate  outcomes of 
genetic counseling to measure, a number of outcomes have historically been considered, 
measured, and researched. One rapid systematic review of outcome studies in genetic 
counseling reviewed 23 studies that met their inclusion criteria and found that common 
reported outcomes of genetic counseling include: knowledge, anxiety and distress, 
satisfaction, perceived risk, genetic testing intention or receipt, health behaviors, and 
decisional conflict (Madlensky et al., 2017). This study also found that from those 
studies, which were primarily in cancer genetic counseling, genetic counseling has been 
suggested to increase knowledge, perceived personal control, positive health behaviors, 
and risk perception accuracy, and to decrease short-term anxiety, cancer-related worry, 
and decisional conflict (Madlensky et al., 2017). A systematic review of randomized 
control trials (RCTs) in genetic counseling reviewed 58 publications of 54 RCTs which 
were also primarily from cancer genetic counseling that assessed “enhancements” to 
genetic counseling or compared multiple delivery modes (Athens et al., 2017). The 
review similarly found that common reported outcomes included: psychological 
wellbeing, knowledge, perceived risk, and patient satisfaction. However, the review 
noted that “disparate validated and reliable scales and other assessments were often used 
to evaluate the same outcome(s),” which makes comparison of findings across studies 
more difficult and less generalizable. Longer term outcomes such as coping, adaptation, 
and adjustment to a genetic diagnosis have also been measured. Broadly, genetic 
counseling outcomes include cognitive, affective and decisional outcomes and the 
preponderance of evidence points toward impact on shorter term outcomes. 
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Client Personal Characteristics 
 In medicine--and genetic counseling--patients’ inherent personal factors and 
characteristics contribute to how they respond to information, how they engage in their 
healthcare, and how they think and feel after their clinical encounter. However, more 
research is needed to better understand whether and to what degree personal factors 
impact outcomes. Demographic factors such as race, sex, socioeconomic status, age, and 
other characteristics have been suggested to make a difference in the decisions patients 
make, their emotional reactions to, and their degree of  engagement in a medical setting 
(Kaphingst et al., 2016; Cooper & Roter, 2003). In the breast cancer setting, African 
American women have been less likely to pursue testing, and have been found to be less 
likely to follow through with recommended screening guidelines than Caucasian women 
(Armstrong et al., 2005; Butrick et al., 2015; Cragun et al., 2015). By looking for 
associations between demographic factors of research participants and genetic counseling 
outcomes, researchers may be better able to understand differences in responses to 
communication of information.  
Genetic Literacy 
 In healthcare, health literacy, or the “degree to which individuals have the 
capacity to obtain, process, and understand basic health information and services needed 
to make appropriate health decisions” can impact short and long-term outcomes for 
patients, including engagement in their care (HHS, 2000). Kaphingst and colleagues 
studied 624 patients in primary care at a large urban hospital that serves underserved 
populations, and found that genetic knowledge, health literacy, self-efficacy, and 
communication were all related to differences in perceived importance of genetic 
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information and family health history (Kaphingst et al., 2016). Another study in a 
colorectal cancer cohort found that those with lower health literacy were less likely to 
receive chemotherapy than those with higher health literacy (Busch et al., 2015). 
Genetic literacy has been defined as a subset of health literacy and “the ability of 
an individual to understand concepts important to the use of personal genetic 
information” (Erby et al. 2008). In genetics health care, genetic literacy can impact 
clients’ perceptions, decisions, and outcomes. In a study looking at perceptions of 257 
individuals with inflammatory bowel disease, those with higher genetic literacy had 
higher appraisals of the utility of genetic testing for IBD than those with lower genetic 
literacy (Hooker et al., 2014). Genetics information is often complex and unfamiliar to 
individuals who have had little to no prior exposure to genetics education. When patients 
and clients are faced with making nuanced informed decisions in genetic counseling,  low 
genetic literacy can be a barrier to fully engaging in the information and considering how 
that information may impact their lives.  
Patient-Provider Orientation 
 Patients have preferences about their interactions with providers that can affect 
how those interactions unfold as well as how satisfied patients are after receiving care.  
Preferences about providers, such as how directive or “paternalistic” patients expect or 
want their providers to be can differ from one  patient to the next (Redsell and Buck, 
2009). One framework for patient-provider orientation considers this characteristic across 
a  spectrum from “disease-” or “doctor-centered” to “patient-centered” (Krupat et al., 
2000). When the model of healthcare from the provider matches with the patient’s 
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patient-provider orientation, satisfaction with care has been shown to be higher (Krupat, 
et al., 2000).  
In the health setting, just as the client brings his or her own characteristics into the 
clinical encounter, so does the provider. The provider may or may not have a 
communication style that aligns with the patient’s preferred orientation. In addition, 
implicit biases (racial and otherwise), provider goals for the session, communication 
style, focus on patient-centered care (including partnering language), and beliefs about 
the importance of specific information are among the factors that may vary across 
providers. It is important for patient-provider interaction studies to consider how patient 
characteristics--including demographic characteristics, genetic literacy and patient-
provider orientation--affect patient outcomes, as well as to separately consider how 
patient characteristics and provider characteristics contribute to outcomes. There are 
many variables to consider, necessitating creativity in study design.  
 
Hypothetical Study Designs with Analogue Clients  
 Rather than observing a traditional genetic counseling session and controlling for 
multiple in-session variables, an analogue client (study participant) can be given an 
experimentally controlled hypothetical scenario and can be asked to act and respond to 
questions as if the scenario applied to him or her. The use of an analogue client or patient 
allows for manipulation of one or more content or process elements that would be 
difficult to manipulate in an in-person medical (or other) interaction. Hypothetical 
vignettes have been described as “useful research tools yielding valuable data when 
studying people’s attitudes, perceptions and beliefs” (Hughes, et al., 2002), and one 
review of 18 experimental video-vignette studies found that this method proved to be an 
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effective way to manipulate communication, that vignettes in well-designed studies are 
perceived to be realistic, and that observers or participants in these scenarios are able to 
put themselves into the scenarios (Hillen et al., 2013). Persky and colleagues reviewed 38 
analogue studies to assess the hypothetical scenario methodology in genetic susceptibility 
testing, and their summary suggests that this methodology can be a useful tool, as long as 
rigorous scientific research design is upheld (Persky et al., 2007). The use of video 
technologies to experimentally manipulate aspects of healthcare interactions allows 
researchers to isolate specific parts of communication to examine their effects on 
analogue clients, and this methodology has been used in a growing number of patient-
provider communication studies, including studies examining information recall in the 
















- 12 - 
SPECIFIC AIMS AND HYPOTHESES 
 
The objectives of this study were to experimentally examine the relationships 
between the style of genetics information provision by genetic counselors and analogue 
client decisional and affective outcomes, as well as to examine relationships between 
analogue client-specific characteristics and those outcomes. To capture the effects of 
communication complexity on genetic counseling outcomes, elements of adult learning 
theories and oral literacy demand were used to develop three levels of communication 
complexity--high complexity, medium complexity, and low complexity--in a hypothetical 
cancer genetic counseling session. Study participants were asked to imagine themselves 
as the genetic counseling client as they watched a set of videos in one of the complexity 
levels. Demographic information and personal characteristics were collected and survey 
measures and open-ended questions were used to capture outcomes from experiencing 
the video cancer genetic counseling session. 
Aim 1: To assess how characteristics of information provision and complexity affect 
analogue clients’ affective and cognitive outcomes. 
         Sub Aim 1-1: To measure effects of information provision style on emotional 
response and satisfaction. 
Sub Aim 1-2: To measure effects of information provision style on post-
interaction knowledge. 
         Sub Aim 1-3: To capture effects of information provision style on decisional 
outcomes (test decision and decisional conflict). 
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 Sub Aim 1-4: To compare participants’ self-reported engagement between three 
different genetic counselor communication styles. 
● Hypotheses for Aim 1: Broadly, we hypothesize that the low complexity 
communication will perform the best across all outcomes. Based on principles of 
adult learning theory and oral literacy demand, including elements of interactivity 
and plain language use, we have reason to believe that lower communication 
complexity will improve outcomes over high complexity communication. 
Aim 2: To examine the association between clients’ personal characteristics’ 
(demographics, family history, genetic literacy, and patient-provider orientation) and 
outcome measures. 
● Hypotheses for Aim 2: We hypothesize that personal characteristics will 
be associated with genetic counseling outcome measures.  
(1) We predict genetic literacy will be inversely associated with satisfaction, 
perceived respect, and knowledge. 
(2) We predict a patient-provider orientation will be inversely associated with 
satisfaction and respect such that those who expect a more patient-
centered interaction will have lower levels of satisfaction and perceived 
respect. 
(3) We predict perceived personal risk for cancer will be positively associated 
with negative emotional response. 
         Sub Aim 2-1: To examine moderating effects of personal characteristics on links 
between information characteristics and analogue client outcomes. 
● Hypotheses 2-1: We predict genetic literacy, patient-provider orientation,  
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and personal perceived risk for cancer will moderate the effects of communication  
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CONCEPTUAL FRAMEWORK 
 Conceptualization of this study and the examination of communication of genetic 
information draws upon adult learning theory principles and the oral literacy demand 
framework. In order for adults to learn, they need to feel that the information is 
personally relevant to them, and they need to be actively engaged in the learning process 
(Knowles, 2011). Though there are numerous individual theories, broadly, adult learning 
theories emphasize the importance of personal relevance, active engagement in learning, 
using experience to learn, and focusing on a problem (Knowles, 2011). Consideration of 
the oral literacy demand framework goes beyond the learner’s process needs and 
describes characteristics of the provider’s communication (Roter et al., 2007). 
Specifically, the four major components of oral literacy demand include the use of 
medical jargon and technical terminology, language complexity, interactivity, and content 
density. The higher the oral literacy demand, the more difficult it may be for individuals, 
particularly individuals with lower genetics or health literacy or non-native speakers of 
English, to effectively learn and find personal meaning in the information that is given to 
them by the provider. Given that genetic counseling has been shown to be a provider-
dominated and disease-centric conversation, theory would suggest that tailoring the way 
information is communicated could change client engagement in the session and in their 
healthcare, and could potentially impact immediate emotional, decisional, satisfaction, 
and information recall outcomes. More broadly, improving clients’ ability to understand 
the key information content through reducing language complexity and increasing 
engagement in the session could enhance short-term outcomes--including understanding, 
satisfaction, and trust-- which could also have longer term implications for adaptation, 
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health behavior, and overall health outcomes (Street et al., 2009). Thus, understanding if 
and how the complexity of communication impacts client outcomes, and characterizing 
the moderating effects between personal characteristics and communication complexity 
on genetic counseling outcomes could help guide evidence-based practice. 
In our conceptual framework, we have incorporated clients’ personal 
characteristics to represent clients’ factors that may affect how they react to a genetic 
counseling session . As described previously, genetic counselors’ personal characteristics 
are also hypothesized to affect the interaction.  However, our study design holds the 
genetic counselor constant, as  the provider’s personal characteristics are not the focus of 
this study. Within the clinical encounter, communication of genetics information makes 
up a large component of the time and focus of the genetic counseling session. Principles 
of oral literacy demand and adult learning theories can describe elements of the process 
of genetic counseling communication. In our case, these are experimentally manipulated. 
In this framework, within the clinical encounter, patient engagement is affected by the 
provider’s communication of information, and the encounter leads to decisional outcomes 
(i.e. decision to have genetic testing, decisional conflict) as well as affective and 
cognitive outcomes (for example, satisfaction, emotional response, and knowledge 
recall). While our study aims to capture post-session outcomes measured immediately 
following genetic counseling, longer term secondary health outcomes may be affected by 




















Figure 1. Conceptual Framework 
 
Patients come to the clinical encounter with varying personal characteristics. Providers 
likewise have personal characteristics that affect the clinical encounter. Within the 
clinical encounter, communication of genetics information, characterized by factors 
related to adult learning principles and oral literacy demand, affects patient engagement 
with the information, leading to decisional, affective, and cognitive outcomes. The 
communication in the clinical encounter and its short-term outcomes may impact long-
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METHODS  
Study Design Overview 
The study design was a mixed methods experimental design using a hypothetical 
video cancer genetic counseling scenario through an online survey platform (Qualtrics). 
The study was deemed by the NIH Office of Human Subjects Research Protections to be 
exempt from a full IRB review process, as no personally identifiable information was 
linked to study data, retained, or shared. Participants were recruited from two adult 
volunteer cohorts, the NIH Clinical Research Volunteer Program and ResearchMatch. 
Ostensibly “healthy” (without a personal cancer history) volunteers were targeted for this 
study due to the hypothetical nature of the study. The hypothetical scenario involved 
asking the participant to imagine that she was a woman referred for genetic counseling 
after her sister’s recent cancer diagnosis to discuss personal risk and genetic testing 
options available. Inclusion and exclusion criteria were chosen to increase the likelihood 
that the hypothetical scenario would feel real without being so similar as to make it likely 
that a participant would view the research exercise as a replacement for receiving 
personal genetic counseling. Inclusion criteria were English speaking adult women with a 
family history of at least one family member who has had cancer (excluding basal cell 
skin cancer), but with no personal history of cancer (excluding basal cell carcinoma), as 
well as no previous experience meeting with a genetic counselor. Women reporting a 
sister with breast cancer were excluded from study to remove the possibility of conflating 
the study with clinical care and to attempt to avoid more extreme emotional responses in 
the absence of an in-person genetic counselor. The population was limited to English-
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speakers due to validation of survey instruments in English, and the interactive nature of 
the online web-based tool being developed in English. 
Participants were emailed an invitation to participate in the study if they met the 
inclusion criteria, and were directed to follow the link to an online Qualtrics platform if 
they were interested in participating. The participants were presented with an online 
consent document and then asked if they wished to participate and also asked to verify 
that they met the inclusion requirements for the study. The platform was self-directed, 
and participants could proceed at their own pace through collection of demographic 
information, surveys, watching the genetic counseling videos, post-counseling surveys, 
and open-ended questions.  
 
Description of Study Participant Populations 
Clinical Research Volunteer Program (CRVP) at the National Institutes of Health  
The Clinical Research Volunteer Program (CRVP) is comprised of individuals 
who have contacted the National Institutes of Health (NIH) to give permission to 
researchers to recruit them for research study participation. These individuals are 
considered “healthy” volunteers without a known or stated health condition. The 
individuals in the Clinical Research Volunteer program are generally of higher 
socioeconomic status than the general population, have proactively volunteered for NIH 
research, and are thus possibly more willing and engaged in participating in the 
experimental web-based study design than members of the general public. Due to specific 
recruitment at the NIH to increase racial diversity for a separate ongoing NIH study 
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known as ClinSeq, the “A2” ClinSeq cohort, comprised of African Americans, comprises 
up to 30% of potential research participants in the group. 
ResearchMatch 
 The ResearchMatch cohort is comprised of individuals who have contacted the 
national ResearchMatch registry to give permission to researchers nation-wide to recruit 
them for research studies or use their self-reported health data for analysis. These 
individuals self-report any health information and problems they wish to disclose into the 
ResearchMatch database. Similar to the CRVP, the participants have higher 
socioeconomic status than the general population, and over 90% of the participants are 
white. When recruiting through ResearchMatch, the researcher has the ability to sort 
participants by specific qualities, and women over 18 who reported no personal history of 




 Study participants were recruited through CRVP and ResearchMatch. For the 
CRVP participants, a CRVP staff member sent recruitment emails to potentially eligible 
participants inviting them to either contact the researcher directly (first recruitment set) or 
to follow a direct online link to the study (subsequent recruitment sets) (See Appendix 
A). For ResearchMatch, the researcher was granted access to the database, and filtered 
potential participants by the inclusion criteria in order to generate a random list of eligible 
participants. From that set, the research selected a subset to generate a list of race-
matched eligible participants, based on the racial demographics of the CRVP cohort 
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(which has ~25-30% non-Caucasian participants). Emails were sent through the 
ResearchMatch system directly to that subset, and recipients selected whether or not they 
wished to be contacted about participation. From there, the researcher was able to send a 
direct email with the link to the study.  
 
Pilot Study 
Piloting of the survey and the online platform was performed remotely with three 
NIH CRVP volunteers who met study eligibility criteria. The participants completed the 
study while on the phone with the researcher, and were asked to speak aloud about any 
issues (technical or otherwise) they were having or portions that were confusing. At the 
end of the survey, the researcher asked additional questions about what could be done to 
improve the study in clarity, ease, and efficiency, as well as how to increase the 
likelihood of participants completing the entire survey. Average timing of the survey was 
also recorded in the piloting phase, in order to attempt to keep the completion time 
between 30-45 minutes. Minor changes were made based on the participant feedback, 
including wording clarification and the addition of “N/A” to the family history questions. 
 
The Study Instrument 
Consent and Human Verification 
 Consent was obtained electronically through the first web page of the Qualtrics 
survey (see Appendix B). Description of benefits, potential risks, participation 
requirements, and contact information of the researchers was provided should the 
participant have any questions or concerns. In order to prevent fraudulent participation, a 
human verification reCAPTCHA was used. Additionally, participants were only allowed 
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to complete the survey once. Participants who did not meet eligibility criteria were 
diverted from continuing the rest of the survey through built-in screening questions 
administered after the consent process. 
Participant Personal Characteristics 
 Participant demographic information was collected including: age, race, ethnicity, 
education, income, marital status, and number of biological children (See Appendix C for 
full study instrument). Personal family history information was collected to quantify the 
number of affected individuals and the types of cancers in the family, specifically a 
family history of breast and/or ovarian cancer and male breast and/or prostate cancer. To 
further qualify the participant’s perception of personal risk for developing cancer, she 
was asked what she thought about her own risk of developing cancer in the future, with 
responses ranging from (1) much lower than average to (5) much higher than average. 
This method of collecting personal perceived risk for cancer has been adapted from work 
from Rubinstein and colleagues who surveyed 2,505 women about their family histories 
to examine how disease perceptions for cancer were associated with family history 
(Rubinstein et al., 2011). 
 Beyond demographic characteristics and family history, genetic literacy level and 
patient-provider orientation were collected using validated and widely used measures. 
Genetic literacy was measured using the Genetic Literacy Comprehension (GLAC) 
measure adapted from the Rapid Estimate of Adult Literacy in Genetics (REAL-G) short 
measure to capture genetic literacy in a survey format by combining familiarity of 
genetics-related words with correctly selecting the appropriate term to use in a sentence, 
in total of 18 questions (Erby et al., 2008; Hooker et al., 2014). For each individual, 
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familiarity scores are averaged and added to the number of correctly matched words in 
the provided sentences, with a possible score range of 0.2-15, with a higher score 
indicating higher genetic literacy.  
Additionally, patient-provider orientation was collected using the Patient-Provider 
Orientation Scale (PPOS) (Krupat et al., 2000). Patient-provider orientation is a measure 
of how individuals prefer and expect to interact with their healthcare providers. The scale 
is comprised of 18 questions, divided into “sharing” and “caring” scales (Krupat et al., 
2000). Our version used a 7 point Likert scale from (1) “Strongly Disagree” to (7) 
“Strongly Agree”. Taken together, a higher total mean score is indicative of preference 
for patient-centered care while a lower mean scores is indicative of a preference for 
“disease-” or “doctor-” centered care. For the purposes of our study, we collected 
“sharing,” “caring,” and the combined patient-provider orientation scores to capture a 
more robust impression of how participants think and feel a provider should interact with 
them.  
 
Hypothetical Scenario Description 
 After collecting participant characteristics, the participants were directed to 
consider the following hypothetical scenario:  
“Imagine that you have a sister and that she was recently 
diagnosed with invasive breast cancer at the age of 39. She suggested that 
you meet with a genetic counselor about your risk for breast cancer, and 
an optional genetic test that could be available to you if you were 
interested. Today, you’ll be watching videos that represent what genetic 
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counseling sessions might look like, and you’ll be asked a series of 
questions about your thoughts, feelings, and experiences overall after 
viewing the videos. 
 The genetic counselor may also ask you questions during the 
session. While we won’t be recording your responses to those questions, in 
order to enhance the reality of the videos, please respond when the genetic 
counselor poses a question (out loud or in your head). Please answer the 
questions as if this were a real situation, but also remember that this in no 
way reflects your actual personal risk for breast and ovarian cancers.” 
This particular scenario was chosen because, as awareness of genetic testing 
expands, having a close family member with early-onset cancer is an increasingly 
common reason for clients to present to genetic counseling. In addition, a similar scenario 
was used in the GCVP, providing a model for typical information provision in this 
context (Erby et al., 2006).  
 
Development of the Simulated Cancer Genetic Counseling Videos 
 Scripts for the video cancer genetic counseling sessions were developed through a 
combination of using previously-collected cancer genetic counseling transcripts from the 
Genetic Counseling Video Project (GCVP), audio recordings from a more recent but as 
yet unpublished graduate study (Setzer et al., unpublished), the student’s (EB) clinical 
training experience in a cancer genetic counseling clinic, and consulting with two 
practicing genetic counselors for reality and accuracy in informational content. 
Transcripts from the GCVP with the highest scores in self-reported similarity to actual 
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practice were first selected to prioritize reality of practice. Informational points (i.e. risk 
figures, discussion of genes, inheritance patterns, etc.) as well as wording of explanations 
of those points were noted. Other aspects of communication, including question asking 
and checking for understanding  (i.e. “Okay?”) were also noted. Audio recordings from 
Setzer’s more recent communication study were used to corroborate the informational 
content as well as to note any changes in focus since the GCVP was conducted (i.e. 
mention of gene panels beyond BRCA1 and BRCA2, variants of uncertain significance, 
GINA) (Setzer, unpublished; Roter et al., 2006; Hooker et al., 2017).  
A written draft of the informational components of a typical pre-test genetic 
counseling visit was developed based on these two sources. Scripts were designed to 
include all of the parts of a typical pre-test genetic counseling session that involved 
information provision. Family history and medical history information gathering, as well 
as any personal exploration of clients’ values and the personal meaning of information 
were excluded, as they were not considered to be part of information provision. The first 
script was developed to reflect the highest communication complexity, based on what 
was noted in the GCVP transcripts, and the other two scripts were developed afterwards. 
In order to create three distinct scripts of increasing levels of complexity, 
quantitative measures of language complexity and aspects of oral literacy and adult 
learning principles were modified. Elements including Flesch-Kincaid reading level, 
medical jargon, words per sentence, percentage of passive sentences, “you” statements, 
open-ended questions, and teach-back utilization were altered. Medical jargon use was 
approximated using a method recently developed by Erby and colleagues that quantifies 
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the use of more than 4000 pre-identified medical jargon terms (Erby et al, unpublished). 
The summary of the differences between the three levels is summarized in Table 1. 
 The high complexity script was designed to be highest in language complexity, 
lowest in interactivity, with minimal checks for understanding, and no teach back. The 
low complexity was designed to have lowest language complexity, highest interactivity, 
and more checks for understanding including teach back. The medium complexity was 
designed to be intermediate between the two, with language complexity levels between 
the other two levels, but with interactivity and teach back similar to the low complexity. 
Compared to the high complexity, the medium complexity used more plain language but 
the same amount of informational details, and the low complexity had both more plain 
language and fewer informational details, though the same general factual concepts were 
included in all three complexities. Even within the high complexity videos, great care 
was taken to ensure that language use was similar to sessions included within the GCVP 
simulation study of routine care.  
To approximate interactivity, each arm progressed as a series of consecutive 8-17 
short videos (4 seconds to ~8 minutes in length) during which the genetic counselor in 
the video would talk and then pause for the client to consider what her response would 
have been had she been sitting in a real session before moving on to the next video in the 
series. The shortest video clips were clips of the genetic counselor prompting the 
participant with a question, and the longer clips contained communication of information. 
There were more videos in the medium and low complexity levels (17 each compared to 
8 in the high level), approximating more interactivity with the same basic informational 
concepts included. The medium and low complexity levels also included additional open 
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ended questions to prompt engagement beyond answering “yes” or “no”. The average 
time and total time of these videos was also shorter than the “High” complexity videos, 
allowing more time and opportunities for the participant to engage verbally or mentally. 
Sessions with more technical information and medical jargon have been shown to be 
longer in the GCVP (Roter et al., 2007).  
After the three scripts were developed, a practicing genetic counselor edited the 
scripts for clarity and language. Following those revisions, an additional practicing 
cancer genetic counselor was then consulted to review the reality, validity, and accuracy 
of the information in the scripts, and a third practicing genetic counselor edited the scripts 
for clarity and language before finalizing the scripts (refer to Appendix D for full video 
scripts). To maximize reality of the videos, a practicing genetic counselor comfortable 
and familiar with genetics concepts served as the genetic counselor in all videos for all 
three communication complexity levels. 
 
Randomization 
 The Qualtrics online study platform automatically randomly assigned each 
participant to watch one set of genetic counseling videos (High, Medium, or Low 
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Table 1. Video Dialogue Script Complexity Measures 
 
 
Complexity Measure High Medium Low 
Flesch-Kincaid Reading Level 10.2 8.0 7.2 
Medical Jargon 466 uses 344 uses 200 uses 
Turn Taking 7 17 17 
Total Words 3666 3196 2742 
Words/sentence 19.9 16.4 14.9 
Passive Sentences 13.6% 12.8% 11.6% 
“You” Statements 132 148 142 
Open-Ended Questions 3 11 15 
Teach-Back Utilized No Yes Yes 
Number of Videos 8 17 17 








Total Video Length of all videos  21 min 18 min 12 min 
 
Communication complexity level was varied across three levels (High, Medium, and Low) in video clips of 
a genetic counselor speaking to the hypothetical patients. Quantitative measures of oral literacy demand 
and language complexity were altered to reflect differences across the three levels.  
 
Table 2. Length of Video Clips  
 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
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52s 8s 59s 1m 
7s 
7s 






12s 42s 52s 59s 26s 6s 
 
H: High complexity 
M: Medium Complexity 
L: Low Complexity 
 
The amount of time in each video clip for each complexity level is summarized. The study participant was 
prompted with a question or thought at the end of each clip, representing interactivity and turn taking.  
Content in each respective video clip number (e.g. #5 in high vs. #5 in medium) is not assumed to be the 
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Outcome Measures and Scales 
(1) Genetic Test Decision  
Following the video genetic counseling session, participants were prompted with 
the question, “If you were the client seeing this genetic counselor, would you want to 
have genetic testing today?” and asked to select, “Yes,” “No,” or “Maybe” before 
proceeding to the remainder of the survey.  
(2) Emotional Response 
 In order to gather the emotional response from the video genetic counseling 
experience, a scale which has been validated and utilized in the GCVP and previous 
genetic counseling research was used (Roter et al., 2006; Butrick et al., 2011). This scale 
asks the survey taker to select how strongly they are feeling each of the following seven 
emotions: fear, ease of mind, confusion, confidence, frustration, and difference from 
others on a 7-point Likert scale from None (1) to Very Much (7). Scores for positive 
emotions (ease of mind and confidence) and negative emotions (fear, confusion, 
frustration, different from others) are totaled. 
(3) Decisional Conflict 
 Decisional conflict is an outcome measure which goes beyond positive and 
negative emotional reactions to capture specific feelings and thoughts about the decision 
individuals made (O’Connor, 1995). The decisional conflict scale has been used broadly 
in medical and genetic counseling settings, including in cancer settings, to quantify how 
conflicted individuals feel about health decisions they have made (or hypothetically 
made) (Katapodi et al., 2011). The scale is divided into three subscales including: 
decision uncertainty, factors contributing to uncertainty, and perceived efficacy in 
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decision making. The scale is a 16 question 5-point Likert scale from “Strongly Agree” 
(1) to “Strongly Disagree” (5), with a higher score indicating higher decisional conflict. 
Negative questions are reverse scored so that all questions are in the affirmative, and an 
average score can be derived from all 16 questions. 
(4) Perceived Respect from the Provider 
 Participants were asked to rate to what degree they felt respected by the video 
genetic counselor (“My genetic counselor has a great deal of respect for me”) on a scale 
from (1) Strongly Agree to (5) Strongly Disagree. This method of collecting perceived 
respect has been used in similar studies (Butrick et al., 2011). 
(5) Genetic Counseling Satisfaction 
 Previous studies have shown that patients are generally satisfied with genetic 
counseling (Veach et al., 1999; Shiloh et al., 1990), but we aimed to detect a difference in 
satisfaction between the three communication complexity levels and/or to detect 
differences between participants based on specific personal characteristics. Satisfaction 
with the genetic counseling session was gathered using the validated Genetic Counseling 
Satisfaction Scale (GCSS) widely used in genetic counseling, and validated in cancer 
genetic counseling specifically, to measure satisfaction outcomes of genetic counseling 
(Tercyak et al., 2001; DeMarco et al., 2004). 
(6) Knowledge 
 In order to measure post-counseling knowledge, participants were given 10 true or 
false questions to answer about cancer and genetics. The questions were drawn from a 
cancer knowledge recall test, a validated scale to measure knowledge based on main facts 
typically conveyed in cancer genetic counseling, and wording was altered to reflect 
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language in the video scripts (Lerman et al., 1997). All factual points on the test were 
included in each set of the videos, regardless of complexity level. Pre-test knowledge was 
not evaluated so as not to prime the participants to attend to specific pieces of 
information.  
(7) Verisimilitude and Similarity to Other Health Care Received 
 The video genetic counseling sessions and hypothetical scenario may have 
detracted from verisimilitude for the participants, and we wanted to see if there were any 
differences across complexity levels and to generally characterize the experience overall. 
We wanted to understand how it felt for the participants to watch the videos and place 
themselves in the hypothetical scenario, so they were asked:  
 “How easy was it for you to take on the patient role when viewing the video 
genetic counselor?” (1- Very difficult to 4- Very easy) 
 “How real did the genetic counselor in the video seem?” (1- Not at all real, to 4- 
Very real) 
 “How similar was the genetic counselor to health care you have received in the 
past?” (1- Not at all similar, to 4- Very similar).  
(8) Open-Ended Questions 
Following the videos, participants were asked a number of open-ended questions 
to gather qualitative data about their experience as the client. They were also asked 
questions including what they learned, what information they found most helpful to their 
decision, what information they found most confusing, what else they would have liked 
to say or ask, what else they would have liked to learn, if there was anything they wished 
the researchers to know. These qualitative data were intended to help provide context for 
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the quantitative results as well as offer a more nuanced understanding of the participants’ 
experiences.  
(9) Self-Reported Engagement  
Throughout the video cancer genetic counseling session, the counselor prompted 
the participant to answer open- and close-ended questions. Participants were asked to 
verbally or mentally respond to the questions, though no audio or text data was collected. 
As a rough proxy of engagement, participants were asked to report how often they 
answered questions: “When the genetic counselor asked you a question, how often did 
you answer the question (out loud or in your head)?” (1- Not at all, to 5- All of the time). 
(10) Research Integrity 
 In order to attempt to filter out the data of participants who did not answer the 
surveys honestly or to capture those who sped through the survey to get to the end, 
participants were asked, “The integrity of our research data is important to us. Have you 
answered the survey questions honestly? You will be compensated regardless of your 
answer, and your answer will not be linked to your email address or personal 
information.” 
(11) Contact Information Collection and Future Contact Preference 
 At the end of the study, the Qualtrics platform redirected participants to a separate 
webpage, unlinked to their study data, that asked for an email address and to state a 
preference for whether they wished to be contacted about the results of the study. 
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Sample Size and Power Calculation 
 The primary aim of the study was to detect significant differences in affective and 
cognitive outcome measures between the three randomized communication complexity 
groups (high, medium, and low). A sample size of 260 was calculated to power the study 
to detect the situation in which differences in communication complexity account for at 
least 3% of the variance in the affective and cognitive outcomes. When the 
communication complexity group explains 3% of the variance of the outcomes, and the 
model explains 10% of the variance, at an alpha level of 0.05, 80% power would have 
been achieved in the study.  
 
Analysis Plan 
 This study used a three group experimental design with data collected through an 
online video and survey instrument tool, Qualtrics. The study was a mixed methods 
study, and survey responses produced quantitative and qualitative data. STATA 
Statistical Software was used to analyze the quantitative data, and descriptive analysis 
was used to determine ranges, means, medians, standard deviations, and frequencies for 
all variables. Bivariate (Pearson’s correlations) and multivariate analyses (multiple linear 
regressions) were performed to look for correlations and significant associations between 
variables. To compare outcomes between the three groups, multiple linear regression 
models were created using backwards stepwise elimination of covariates to detect any 
statistically significant differences between the three complexity groups, and a chi 
squared test was used to compare testing decisions across the three groups. The survey 
data were also analyzed using the same backwards stepwise elimination multivariate 
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models to examine the relationships of personal participant characteristics (demographic 
information, genetic literacy, and patient-provider orientation) with each affective and 
cognitive outcome (satisfaction, emotional response, decisional conflict, perceived 
respect, knowledge and information recall, ease, reality, and engagement). Interaction 
effects between complexity and personal characteristics were explored by creating 
interaction terms in multiple linear regression models using personal characteristic 
covariates that were found to be statistically significantly associated with outcomes in the 
original multivariate models. Regression models stratified by complexity level were 
performed to further characterize effect modification in instances where interaction was 
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Table 3. Study Independent and Dependent Variables 
Independent: 
● Demographic Factors:  
○ Age (cont.) 
○ Race (dichot.) 
○ Ethnicity (dichot.) 
○ Marital Status (cat.) 
○ Number of Biological 
Children (cont.) 
○ Education (cont.) 
○ Income (cont.) 
● Reported Family History of Cancer 
(dichot.) 
● Perceived Personal Risk of Cancer 
(cont.)  
● Genetic Literacy (GLAC) (cont.) 
● Patient-Provider Orientation 
(PPOS) (cont.)    
Dependent: 
● Genetic Test Decision (cat.) 
● Emotional Response (cont) 
● Decisional Conflict (cont.) 
● Cancer Knowledge (cont.) 
● Satisfaction in GC (cont.) 
● Perceived Respect from GC (cont.) 
● Verisimilitude (Ease of Imagining 
Self as Client, Reality of GC) 
(cont.) 
● Perceived Similarity of Video GC 
to other Healthcare Experiences 
(cont.) 
● Self-reported Engagement in GC 
Session (cont.) 
  
cont.   treated as continuous variable  
 cat.   treated as categorical variable 


















- 36 - 











































Total Contacted: 6488 
CRVP Contacted: 2488 
ResearchMatch Contacted: 4000 
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RESULTS  
 
Recruitment and Completion Rates 
 Study recruitment began with the CRVP. 263 eligible individuals who had joined 
the CRVP within the last year were randomly selected from the participant database, and 
were emailed an invitation to contact the researcher for more information about 
completing the study. Around 50 participants replied that they would be interested in 
participating. Three of those individuals participated in the pilot study, and the remaining 
were later sent a link to the Qualtrics study to participate. Following the first recruitment 
emails, additional emails were sent to eligible CRVP who had joined the CRVP in the 
last four years, in batches of 500-1000. A total of 2,488 CRVP participants were invited.  
 In order to boost study participant numbers, ResearchMatch was used as an 
additional recruitment method. Lists of race-matched (~25-30% non-Caucasian) eligible 
participants were generated from the database of over 120,000 total participants. Using 
the internal database, lists containing a total of 6000 Caucasian women were generated 
and from those lists, a total of 3,000 were randomly selected to be recruited. In the same 
way, multiple lists containing a total of 3,000 non-Caucasian women were generated, and 
a total of 1,000 were randomly selected to be recruited. In total, 4,000 women 
participants were contacted with the option to learn more about the study. From the 4,000 
contacted, 215 agreed to be contacted further about the study, and those individuals were 
sent a link to the Qualtrics survey.  
 From the 6,488 individuals that were invited to participate from both cohorts, 
2,703 were ultimately given the link to the survey. Of those 2,703, there were a total of 
503 attempts at the study, and 305 completed studies, and 15 who indicated that they 
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were not eligible to complete in the screening question, resulting in about 60% 
completion from those who were eligible that began the survey. The completion rate from 
all that were invited to participate was 4.7%, and the completion rate from those that 
were given the study link was 11.3%. Of the 183 that did not fully complete the study, 46 
(23%) did not proceed past the consent page and 81 (44%) quit while taking the personal 
characteristic surveys before watching the genetic counseling videos. Overall, 43 (24%) 
quit while watching the videos (18 in high, 15 in medium, 10 in low), 4 (2%) quit 
immediately after making a genetic test decision (2 in high, 2 in medium), and 9 (5%) 
quit while taking the post-counseling surveys (7 in medium, 2 in low). Table 4 
summarizes completion rates by complexity level, and shows that the majority of those 
that quit before completion quit before watching the genetic counseling videos (67%).  
 Of the total 305 completed at the time that the study was closed, 9 responded 
“No” to the question asking if they had answered the questions honestly and were 
removed from the dataset. Upon examination answers from those 9 participants 
demonstrated several potential problems including: incomplete responses, responses that 
demonstrated a predictable pattern, and multiple surveys that were taken around similar 
time points. For the purposes of our study, data were analyzed from the first 286 
participants that completed the survey and self-reported that they had been honest in their 
answers, as the remaining 19 surveys were received at a later date. 
Among the 286 participants included in the analysis, there was very few missing 
data. However, 34 participants did not report their age. In order to analyze the data from 
as many participants as possible, imputation using the median age of 38.5 was used to fill 
missing age data points. Data tables include the number of participants (N) that answered 
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each measure or survey question. Missing data for other independent or dependent 
variables besides age were dropped from analysis for that covariate, as most measures did 
not have more than two or three missing data points.  
 
Participant Personal Characteristics 
 
Demographics 
 The sociodemographic characteristics of the study population are summarized in 
Table 5, and the number of included data points are noted. The participants ranged in age 
from 19 to 78, with a mean of 41.62, and a median of 38.50. The majority of participants 
self-reported as Caucasian (69.7%) and non-Latina (93%). For the purposes of our 
analysis, race was dichotomized into Caucasian and non-Caucasian individuals due to the 
relatively low proportion of individuals in non-Caucasian racial groups. As expected, the 
population was highly educated, with the majority having a college degree or above 
(80%), and more than 45% reporting a graduate degree. The largest proportion of 
individuals fell into the income category of making more than $100,000 per year 
(30.77%), but income was spread across all levels. 45.80% of the participants were 
single, 36.36% were married, 11.54% were divorced, 2.45% were widowed, and the 
remaining 3.50% stated “Other,” with self-reported qualifiers such as “separated,” 
“cohabiting,” and “domestic partners.” The average number of biological children the 
participants had was 0.90, rounded to 1 child, with a range from zero to five. Chi squared 
( χ2) tests were used to detect significant differences between the high, medium, and low 
complexity groups for categorical and dichotomous variables, and ANOVA was used to 
detect significant differences for continuous variables, and no significant differences 
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were found across the three complexity groups for any of the personal characteristics (p-
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Table 4. Summary of Incomplete Surveys 
Quitting Time Point Number of participants that quit the study (%)                   Total Quit = 183 
Prior to Consent 46 (23%) 
Pre-video Surveys 81 (44%) 







During Videos 18  15 10 43 (24%) 
Immediately After 
Videos 
2 2 0 4 (2%) 
Post-video surveys 0 7 2 9 (5%) 
 
 
The number of participants that quit the survey before completion are summarized, including the time point 
within the survey at which they quit. The majority of potential participants quit the study prior to 
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Table 5. Participant Demographics 
  









or χ2  
p-value 















Race  N=93 N=97 N=96 N=286 p=0.938 
(χ2 ) 
 Caucasian 66 (70.97%) 67 (69.07%) 66 (68.75%) 199 (69.6%)  
 Non- 
Caucasian 









18 (19.35%) 14 (14.43%) 21 (21.88%) 53 (18.5%)  
 Asian or 
Pacific 
Islander 





1 (1.08%) 0 (0%) 0 (0%) 1 (0.35%)  
 Other 4 (4.30%) 5 (5.15%) 1 (1.04%) 10 (3.5%)  
 Identify as 
more than 
one 
0 (0%) 6 (6.19%) 5 (5.21%) 11 (3.8%)  




 Hispanic or 
Latina 




87 (94.57%) 87 (90.62%) 92 (96.48%) 266 (93%)  
 
A χ2 test was used to identify differences between the High, Medium, and Low Complexity groups. 
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Table 5 cont. Participant Demographics continued 
 







or χ2  
p-value 
Education  N=93 N=97 N=96 N=286 p=0.451 
(ANOVA) 
 Less than 
High School 
0 (0%) 0 (0%) 0 (0%) 0 (0%)  
 High school 
graduate (or 
equivalent) 




10 (10.75%) 14 (14.43%) 8 (8.33%) 32 (11.19%)  
 Associate’s 
degree 
4 (4.30%)  5 (5.15%) 5 (5.21%) 14 (4.90%)  
 Bachelor’s 
degree 
36 (38.71%) 34 (35.05%) 28 (29.17%) 98 (34.27%)  
 Graduate or 
Professional 
degree 






 N=93 N=97 N=96 N=286 p=0.7124 
(ANOVA) 
 <$25,000 12 (12.90%)  8 (8.25%) 12 (12.50%) 32 (11.19%)  
 $25-50,000 15 (16.13%) 25 (25.77%) 17 (17.71%) 57 (19.93%)  
 $50-75,000 25 (26.88%) 16 (16.49%) 20 (20.83%) 61 (21.33%)  
 $75-
100,000 
18 (19.35%) 13 (13.40%) 17 (17.71%) 48 (16.87%)  
 >$100,000 23 (24.73%) 35 (36.08%) 30 (31.25%) 88 (30.77)  
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Table 5 cont. Participant Demographics continued 
 















 Single 41 (44.57%) 45 (46.39%) 45 (46.88%) 131 
(45.80%) 
 
 Married 37 (40.22%) 32 (32.99%) 35 (36.46%) 104 
(36.36%) 
 
 Divorced 7 (7.61%) 14 (14.43%) 12 (12.50%) 33 (11.54%)  
 Widowed 4 (4.35%) 1 (1.03%) 2 (2.08%) 7 (2.45%)  
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Family History of Cancer and Perceived Personal Risk of Cancer (Tables 6 and 7) 
A summary of the self-reported family histories of cancer are described in Table 
6.  As per inclusion criteria, all participants had a family history of cancer, and reported 
family histories of individuals with cancer varied across the participants, with some 
having first degree relatives with cancer and others having more distant relatives with 
cancer. For the purposes of analysis, family history was dichotomized into individuals 
who had at least one first degree relative with breast (male or female), ovarian, and/or 
prostate cancer and those who did not. 69 participants (24%) had at least one first degree 
relative with breast, ovarian, and/or prostate cancer (22 participants in high, 24 in 
medium, and 23 in low complexity). Regarding perceived cancer risk prior to watching 
the videos, participants generally perceived themselves to be between “lower risk than 
average” and “about the same as average,” with an average perceived risk of 2.80 on a 
scale from 1 (much lower than average) to 5 (much higher than average). ANOVA found 
no significant differences between complexity groups for dichotomized family history or 
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At least one 1st 
degree relative  
















15 (16.1%) 15 (15.5%) 15 (15.6%) 45 (15.7%)  
 Other  22 (23.7%)  20 (20.6%) 30 (31.3%) 72 (25.2%)  
1st degree male 
relative 
      
 Male 
Breast  
2 (2.2%) 1 (1.0%) 1 (1.0%)  4 (1.4%)  
 Prostate 7 (7.5%) 12 (12.4%)  10 (10.4%)  29 (10.1%)  
 Other 26 (28%) 21 (21.6%)  27 (28.1%)  74 (25.9%)   
2nd degree or 
higher female 
relative 




45 (48.4%)  50 (51.5%)  48 (50.0%) 143 (48.3%)  
 Other 48 (51.6%)  48 (49.5%)  42 (43.8%)  138 (48.3%)   
2nd degree male 
relative 
      
 Male 
Breast 
3 (3.2%)  6 (6.2%)  0 (0%)  9 (3.1%)   
 Prostate 16 (17.2%)  14 (14.4%)  24 (25.0%)  54 (18.9%)   
 Other 43 (46.2%)  52 (53.6%)  40 (41.7%)  135 (47.2%)   
 
A χ2 test was used to identify differences between the High, Medium, and Low Complexity groups for 
having at least one 1st degree relative with breast, ovarian, and/or prostate cancer. This was the 
dichotomous variable was the covariate approximating family history used in multivariate analyses. 
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Table 7. Perceived Personal Cancer Risk Scores Summary 
 

























A summary of perceived personal cancer risk scares are summarized by complexity level. ANOVA was 
used to identify differences between the High, Medium, and Low Complexity groups. No significant 
difference between groups was found.  
 
 
Figure 3. Frequency Distribution of Perceived Personal Risk of Cancer 
 
        Personal Perceived Risk of Cancer 
 
 
Distribution of perceived personal risk for cancer across all participants (N=286) are shown. 
Participants tended towards feeling that their risk was “about the same as others” (Average = 2.80 
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 Genetic Literacy (Table 8) 
As reported in previous studies with the CRVP population, genetic literacy 
approximated by the GLAC short measure was high, with an average of 14 on a scale 
from 0.25 (low genetic literacy) to 15 (high genetic literacy). ANOVA found no 
significant differences between complexity groups for genetic literacy. Frequency 
distribution of GLAC scores across the study participants are depicted in Figure 4.  
Patient-Provider Orientation Scale (Table 9) 
Patient-provider orientation tended towards the patient-centered orientation. The 
average PPOS score across all participants was 5.24 on a scale from 1 (disease- or doctor-
centered) to 7 (patient-centered). The “sharing” subscale of the PPOS, indicating “the 
extent to which the respondent believes that patients desire information and should be 
part of the decision-making process,” showed an average score of 5.30, indicating a 
tendency for participants to prefer a sharing model (Krupat et al., 2000). The “caring” 
subscale, indicating “the extent to which the respondent sees the patient’s expectations, 
feelings, and life circumstances as critical elements in the treatment process,” was 5.62, 
suggesting that the participants prefer a caring model in which their personal values and 
input are important (Krupat, et al., 2000). ANOVA found no differences between 
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Table 8. Genetic Literacy Scores (GLAC) 
 
  










 N=93 N=97 N=96 N=286 p=0.877 












Genetic literacy scores are summarized by complexity level. ANOVA was used to identify 
differences between the High, Medium, and Low Complexity groups. No significant difference 
between groups was found. 
 
Figure 4. Frequency Distribution of Genetic Literacy (GLAC) Scores 
 
        Genetic Literacy  
 
 
Distribution of the scores on the GLAC scale across all participants (N=286) are shown. Genetic  
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Table 9. Patient-Provider Orientation (PPOS) Scores Summary 
 
 










 N=93 N=97 N=96 N=286 p=0.475 



































Patient-Provider Orientation scores are summarized for each complexity group and all participants 
combined (N=286). ANOVA was performed to detect significant differences in PPOS between groups; 
none were found. 
 
Figure 5. Frequency Distribution of Patient-Provider Orientation (PPOS)  
   
             Patient-Provider Orientation Scale Scores 
 
Distribution of scores on the PPOS across all participants (N=286) are shown. Participants tended  
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Bivariate Analysis 
 
Correlations Between Independent Variables 
 Pearson’s correlations were performed to examine relationships between 
independent variables (Appendix E). Bivariate analyses were conducted for each personal 
characteristic variable across all participants. From this analyses we found that older 
women in our cohort were more likely to be Caucasian. Household income levels 
increased with age and education. Non-Caucasian individuals were more likely to have 
lower education levels and lower household income overall. The likelihood of having a 
higher number of biological children increased with age, and decreased with education 
level. Personal perceived risk of cancer score tended to be lower in non-Caucasian 
individuals as well as in individuals with fewer biological children. Interestingly, family 
history (having at least one first degree relative with breast, ovarian, and/or prostate 
cancer) was not significantly positively associated with perceived personal risk of cancer. 
Genetic literacy (GLAC) was positively correlated with education level, and it was lower 
in non-Caucasian participants. A higher score on the Patient-provider Orientation Scale 
(PPOS), indicating higher preference for patient-centered care, was correlated with older 
age, Caucasian race, higher education, higher income, more biological children, and 
higher GLAC scores. 
Correlations Between Predictors and Outcomes 
 Bivariate analyses were also conducted on personal characteristics with measured 
genetic counseling outcomes. These analyses were done for the entire cohort as a single 
group, as well as stratified by complexity level (high, medium, low). Summary tables are 
presented in Appendix E. These bivariate analyses were also performed stratified by 
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complexity level. Differences between the three groups are highlighted in Appendix E, 
showing which personal characteristics were associated with each outcome, and their 
respective correlation coefficients indicating the strength and direction of the correlation.  
 
Multivariate Models 
AIM 1: Communication Complexity Level and Genetic Counseling Outcomes 
 The purpose of Aim 1 was to assess how the complexity level of genetics 
information communication affected clients’ affective and cognitive outcomes. Our 
hypotheses were that there would be significant differences between some of the affective 
and cognitive outcomes across the three complexity level groups, with more favorable 
outcomes for the low complexity group. Tests of skewness and kurtosis were performed 
on all outcome variables, and residual plots were constructed from their respective 
multiple linear regression models to capture normality of each outcome. Though a few of 
the outcomes had some mild skewing or kurtosis, all of the residual plots of the multiple 
linear regression models showed random patterns, errors were centered around zero, and 
there were no signs of unbalanced, heteroscedastic, or non-linear trends. 
 Chi-squared tests were used to compare categorical outcomes (test decision) 
between the three complexity levels. Multiple linear regression (MLR) models were 
constructed for each continuous outcome (decisional conflict, positive and negative 
emotions, satisfaction, perceived respect, knowledge, and verisimilitude) in a stepwise, 
backwards elimination fashion. These models initially contained all personal 
characteristics (age, dichotomized race, education, income, number of biological 
children, marital status, dichotomized family history, perceived personal risk, age, 
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GLAC, and PPOS) and language complexity level before backwards elimination. The 
criterion for exclusion was set at p>0.20, with statistical significance at p=0.05. For the 
multiple linear models, reference groups for categorical variables were: high complexity, 
Caucasian race, and having no first degree relative with breast, ovarian, or prostate 
cancer.  
 
Genetic Counseling Outcomes 
Decisional Outcomes (Tables 10-11, Figures 6-8)  
In examining the decisional outcomes, there was no significant difference in 
decision to have genetic testing following the video genetic counseling session between 
the three complexity groups (chi square p=0.909). Across all three groups, 57.34% chose 
that they would want to do the test (“Yes”), while 27.97% chose that they would not want 
to (“No”), and the remainder 14.69% indicated they would “Maybe” want the genetic test 
(Figure 6).  
Backwards stepwise elimination of variables in multiple linear regression 
modeling for decisional conflict showed that the medium complexity remained in the 
model (p=0.023), though low complexity did not (p=0.5128), with high complexity as the 
reference group (Table 11). Compared to the high complexity group, the medium 
complexity group had decisional conflict scores that were 0.167 points higher when 
controlling for genetic literacy, perceived risk for cancer, income, and race, the other 
variables in the model (p=0.023). Sensitivity analysis was done by removing three 
outliers with the highest decisional conflict, and medium complexity remained in the 
model and the significance level and coefficient were generally unaffected (p=0.025). 
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Participants’ average score on the decisional conflict scale was 2.10, on a scale of 1 (not 
conflicted) to 5 (highly conflicted), indicating a relatively low level of conflict about the 






Table 10. Summary of Decisional Outcomes 








Test Decision  N=93 N=97 N=96 N=286 
 Yes 54 (58.06%) 52 (53.61%) 58 (60.42%) 164 (57.34%) 
 Maybe 25 (26.88%) 30 (30.93%) 25 (26.04%) 80 (27.97%) 
 No 14 (15.05%) 15 (15.46%) 13 (13.54%) 42 (14.69%) 
Decisional 
Conflict 
 N=96 N=96 N=96 N=286 















* p<0.05, **p<0.01, ***p<0.001 
 
Chi-squared tests were performed to look for differences in categorical outcomes between high, medium, 
and low complexity. 
 
Multiple linear regression models with backwards stepwise elimination were constructed to look for 
significant differences between high, medium, and low complexity. Significant p-values (<0.05) indicate a 
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Figure 6. Frequencies of Genetic Test Decision  
  
 
Decision to have genetic testing following the video genetic counseling session are shown by three 
complexity levels. There was no significant difference in the number of participants who chose testing 
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Figure 7. Frequency Distribution of Decisional Conflict 
    Decisional Conflict 
 
 
Distribution of the scores on the decisional conflict scale across all participants (N=286) are shown. 
Decisional conflict was slightly positively skewed, but residual plots of the constructed MLR showed no 
patterns of non-normality.  
 
Figure 8. Boxplot of Decisional Conflict by Complexity Level 
 










Medium complexity remained in the backwards stepwise elimination multiple linear regression of 
decisional conflict (p=0.023). Sensitivity analysis was done to repeat the regression without the three 
outliers above the 75% quartile, and the coefficient term remained statistically significant (p=0.025).  
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Table 11. Regression Model for Decisional Conflict (N=280) 
 
Model 
R2 = 0.0761 
Coefficients 
β Std. Error p-value 
(Constant) 3.007 0.439 0.000 
Medium Complexity 0.167 0.728 0.023 
Genetic Literacy (GLAC) -0.0810 0.0295 0.006 
Perceived Personal Risk of Cancer 0.0928 0.0411 0.025 
Income -0.0360 0.0252 0.156 
Non-Caucasian Race 0.108 0.0789 0.174 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Education  p = 0.8564 
Family History p = 0.8017 
Age  p = 0.7312 
Marital Status p = 0.5530 
Low Complexity p = 0.5128 
Patient-Provider Orientation p = 0.3321 
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Emotional Response (Tables 12-20, Figures 9-11) 
 The backwards stepwise elimination MLR models for positive emotional response 
showed no significant difference between complexity groups, either as one collapsed 
outcome (positive emotion) or as distinct emotions (confidence, ease of mind) (medium 
complexity p=0.648, low complexity p=0.921 compared to the reference high complexity 
group) (Table 13). However, MLR for negative emotion did detect that participants in the 
low complexity arm had significantly lower reported levels of negative emotional 
response as a collapsed variable as well as a significantly lower reported level of 
confusion as a distinct emotion compared to those in the high complexity group (Table 
16, 18). In the low complexity group, negative emotion scores were 0.268 lower than 
those for the reference group (p=0.042) when controlling for genetic literacy, perceived 
personal risk for cancer, and race, the other covariates included in the MLR (Table 16). 
Confusion scores were 0.476 lower in the low complexity group than the reported 
confusion scores in the high complexity group (p=0.009) when controlling for patient-
provider orientation, race, genetic literacy, perceived personal risk for cancer included in 
the MLR (Table 18). No other significant differences in emotional response between the 
complexity groups were found (Tables 12-20).  
Overall, participants experienced feeling varying degrees and combinations of 
positive and negative emotions. Taken together, positive emotions were significantly 
stronger than negative (4.17 vs. 2.66, p<0.0001 by t-test). Both types of positive 
emotions, confidence and ease of mind, had ratings closest to the middle of the scale, 
indicating that they were felt “somewhat” strongly. Of all negative emotions, fear had the 
strongest ratings with a score of 3.57. The other negative emotions did not cross the 
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midlevel (4) (confusion was 2.47, frustration was 2.21, different from others was 2.37), 
indicating that participants tended to experience those emotions to a lesser degree than 
“somewhat” but more than “none”. Negative emotion was slightly positively skewed, but 
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A two-sided t-test was performed to detect if negative and positive emotions were significantly different 
from each other, and mean positive emotion scores were significantly higher than negative (p=0.0001). 
 
Scores for strength of emotional response by complexity level. Emotional response is shown for positive 
and negative emotions, as well as each individual emotion that comprises these two  broader groups . MLR 
was performed to detect significant differences between the complexity levels, and the compared to the 
high complexity level, the low complexity level had lower negative response and lower confusion (p=0.042 
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Figure 9. Box Plot of Positive and Negative Emotional Responses 
 
 

















             *** 
 
Boxplots of overall positive (N=286, Avg=4.17) and negative (N=286, Avg=2.66) emotional responses are 
shown. A two-way t-test was done to determine whether the difference in strength of emotion between 
positive and negative was significant, and positive emotion was found to be significantly higher than 
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Figure 10. Frequency Distribution of Positive and Negative Emotional Response Scores 
 
 
             Positive Emotional Response 
 
 
           Negative Emotional Response 
 
Distribution of the scores for positive and negative emotional response (N=286) are shown. Negative 
emotional response was slightly positively skewed, but residual plots of the constructed MLR showed no 
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Figure 11. Box Plots of Negative and Confusion Emotional Responses  
 
               Negative Emotional Response 
 
                * 
               Confusion 
 
               **  
Boxplots of negative and confusion emotional responses are shown by complexity level. MLR was 
performed to detect significant differences between the complexity levels, and the compared to the high 
complexity level, the low complexity level had lower negative response and lower confusion (p=0.042 and 
p=0.009), controlling for the other variables in the MLR for each of those emotional outcomes. 
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Table 13. Regression Model for Positive Emotional Response (N=283) 
 
Model 
R2 = 0.0898 
Coefficients 
β Std. Error p-value 
(Constant) 4.23662 .9815816 0.000 
Age .0153139 .0059774 0.011 
Genetic Literacy (GLAC) .1445069 .0668147 0.031 
Patient-Provider Orientation -.4804467 .1313999 0.000 
Education -.1324871 .0786395 0.093 
Family History .2681855 .1845982 0.147 
Household Income .1191747 .0610284 0.052 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Low Complexity p = 0.9213 
Non-Caucasian Race p = 0.9126 
Medium Complexity p = 0.6475 
Marital Status p = 0.5813 
Number of Biological Children p = 0.3164 
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Table 14. Regression Model for Ease of Mind (N=283) 
 
Model 
R2 = 0.0803 
Coefficients 
β Std. Error p-value 
(Constant) 6.342236 .7458306 0.000 
Age .0163227 .0066319 0.014 
Education -.1881505 .0834532 0.025 
Patient-Provider Orientation -.4568312 .1442792 0.002 
Family History .3061405 .2034915 0.134 
Income .1247424 .0677042 0.066 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Medium Complexity p = 0.8941 
Marital Status p = 0.8265 
Low Complexity p = 0.7404 
Non-Caucasian Race p = 0.6461 
Perceived Personal Risk of Cancer p = 0.6338 
Genetic Literacy (GLAC) p = 0.3038 
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Table 15. Regression Model for Confidence (N=283) 
 
Model 
R2 = 0.0806 
Coefficients 
β Std. Error p-value 
(Constant) 3.399384 1.133223 0.003 
Age .0141509 .0067269 0.036 
Genetic Literacy (GLAC) .201496 .0725232 0.006 
Patient-Provider Orientation -.5097459 .1475133 0.001 
Family History .2837071 .2086699 0.175 
Income .1030085 .0652822 0.116 
Perceived Personal Risk of Cancer -.1341563 .1044163 0.200 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Low Complexity p = 0.9648 
Non-Caucasian Race p = 0.7983 
Medium Complexity p = 0.6042 
Number of Biological Children p = 0.5436 
Education p = 0.4954 
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Table 16. Regression Model for Negative Emotional Response (N=283) 
 
Model 
R2 = 0.0846 
Coefficients 
β Std. Error p-value 
(Constant) 4.59533 .7361648 0.000 
Low Complexity -.2684003 .131241 0.042 
Genetic Literacy (GLAC) -.1778846 .0505359 0.001 
Perceived Personal Risk of Cancer .2070386 .0730683 0.005 
Non-Caucasian Race .193911 .1390355 0.164 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Medium Complexity p = 0.9827 
Number of Biological Children p = 0.9669 
Marital Status p = 0.8983 
Education p = 0.7580 
Family History p = 0.4673 
Income p = 0.4591 
Patient-Provider Orientation p = 0.4208 
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Table 17. Regression Model for Fear (N=283) 
 
Model 
R2 = 0.0842 
Coefficients 
β Std. Error p-value 
(Constant) 3.187117 .5415543 0.000 
Age -.0138895 .0063239 0.029 
Income .2060448 .0676586 0.003 
Perceived Personal Risk of Cancer .351604 .1014204 0.001 
Education -.1412107 .0822459 0.087 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Marital Status p = 0.9852 
Family History p = 0.6797 
Patient-Provider Orientation p = 0.6459 
Low Complexity p = 0.4534 
Non-Caucasian Race p = 0.2966 
Medium Complexity p = 0.2914 
Number of Biological Children p = 0.2180 
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Table 18. Regression Model for Confusion (N=283) 
 
Model 
R2 = 0.1027 
Coefficients 
β Std. Error p-value 
(Constant) 5.022499 1.183897 0.000 
Low Complexity -.476199 .1823152 0.009 
Genetic Literacy (GLAC) -.3067455 .0714333 0.000 
Perceived Personal Risk of Cancer .2061744 .1027432 0.046 
Non-Caucasian Race .3428456 .196935 0.083 
Patient-Provider Orientation .2345887 .1388014 0.092 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Marital Status p = 0.9405 
Education p = 0.8326 
Family History p = 0.8288 
Age p = 0.7240 
Number of Biological Children p = 0.6660 
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Table 19. Regression Model for Frustration (N=283) 
 
Model 
R2 = 0.0261 
Coefficients 
β Std. Error p-value 
(Constant) 4.676511 1.019378 0.000 
Genetic Literacy (GLAC) -.1700875 .0722473 0.019 
Low Complexity -.2843387 .193279 0.142 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Number of Biological Children p = 0.9556 
Medium Complexity p = 0.8746 
Age p = 0.8040 
Income p = 0.6999 
Non-Caucasian Race p = 0.6264 
Education p = 0.5853 
Patient-Provider Orientation p = 0.4954 
Perceived Personal Risk of Cancer p = 0.4707 
Family History p = 0.4081 
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Table 20. Regression Model for Feeling Different from Others (N=278) 
 
Model 
R2 = 0.0696 
Coefficients 
β Std. Error p-value 
(Constant) 3.751213 1.168572 0.001 
Non-Caucasian Race .6249188 .2103076 0.003 
Low Complexity -.2831016 .1975088 0.153 
Family History .3039993 .2197748 0.168 
Genetic Literacy (GLAC) -.1513044 .0795485 0.058 
Perceived Personal Risk of Cancer .1983449 .1108937 0.075 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Education p = 0.9258 
Income p = 0.8870 
Medium Complexity p = 0.8587 
Age p = 0.7576 
Patient-Provider Orientation p = 0.6481 
Marital Status p = 0.6179 
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Cancer Genetics Knowledge (Tables 21-23, Figures 12-13) 
 Multiple linear regression modeling for knowledge measured by a true or false 
test of cancer genetics facts found no significant differences between complexity levels 
(medium complexity p=0.958, low complexity p=0.653 compared to the reference high 
complexity group) (Table 23). Cancer genetics knowledge was measured using a 
validated knowledge scale comprised of 11 true-false questions related to facts that were 
covered in all three sets of genetic counseling videos. The average score correct was 8.21 
across the three groups (SD 1.68). In general, participants did well on test, but the 
number of correct answers ranged from 3-11, indicating that some participants struggled 
or did not retain the information covered while others got all correct. Knowledge scores 
were slightly negatively skewed, but residual plots of the MLR model constructed 
showed no patterns indicating non-normality. The number and percentage correct for 
each knowledge question are reported in Table 22, with the questions ordered from 
highest overall percentage correct to lowest. Chi squared tests found no significant 
differences between complexity groups for getting a given question correct, though two 
statements reached near significance:  “A woman who has a sister with an altered BRCA 
gene has a 50% risk of having an altered gene herself,” (p=0.070; high 92.47%, medium 
87.63%, low 81.25% correct), and “There are many different genes that cause cancer,” 
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(no significant differences found between complexity levels, Medium p=0.96, Low 
p=0.65) 
 
Cancer genetics knowledge scores are summarized. MLR modeling found no significant differences 





Figure 12. Box Plots of Cancer Genetics Knowledge Scores 




Boxplots of cancer genetics knowledge are shown by complexity level. MLR was performed to detect 
significant differences between the complexity levels, and there were no significant differences found 
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Figure 13. Frequency Distribution of Cancer Genetics Knowledge Scores 
 




Distribution of the scores for positive and negative emotional response (N=286) are shown. Knowledge 
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A woman who does not have an altered BRCA gene can 









































A woman who has a sister with an altered BRCA gene 





















 Tests for ovarian cancer often do not detect a tumor 










Early-onset breast cancer is less likely due to an altered 






























One half of breast cancer cases occur in women who 











Shown are each question included on the cancer genetics knowledge measure and displayed by complexity 
level. Questions are listed in descending order of correctness. Chi-square tests were performed on each 
question to determine if there were significant differences between study arms in correctness for each 
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Table 23. Regression Model for Cancer Genetics Knowledge (N=283) 
 
Model 
R2 = 0.2106 
Coefficients 
β Std. Error p-value 
(Constant) 2.418569 1.185735 0.042 
Genetic Literacy (GLAC) .3247648 .0735891 0.000 
Non-Caucasian Race -.9490996 .2030021 0.000 
Income .1179127 .0657582 0.074 
Patient-Provider Orientation .2182437 .1431706 0.129 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Medium Complexity p = 0.9581 
Age p = 0.9501 
Perceived Personal Risk of Cancer p = 0.6887 
Low Complexity p = 0.6530 
Education p = 0.5995 
Number of Biological Children p = 0.4008 
Marital Status p = 0.3835 
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Genetic Counseling Satisfaction and Perceived Respect from the Genetic Counselor 
(Table 24-26, Figure 14) 
Multiple linear regression (MLR) models exploring the relationship between 
study arm and genetic counseling satisfaction and perceived respect from the genetic 
counselor found no significant differences between complexity levels (medium p=0.965, 
low p=0.473 for satisfaction compared to the reference high complexity group; medium 
p=0.388 low p=0.997 for perceived respect compared to the reference high complexity 
group) (Tables 25 and 26). In our study, participants felt generally satisfied with the 
genetic counseling that they received, with an average satisfaction of 4.01 on a scale from 
1 (not satisfied) to 5 (highly satisfied). Beyond satisfaction, participants were asked to 
what degree they felt respected by the genetic counselor. On average, participants felt 
respected, with responses averaging 4.19 on a scale from 1 (not respected) to 5 (highly 
respected). The range for satisfaction for the high complexity level was 1.33-5, which 
included lower satisfaction scores than both medium (2-5) and low (2.5-5) complexity 
levels, though satisfaction was not significantly lower in the high complexity group. 
Respect and satisfaction were both slightly negatively skewed, as the participants 
generally felt respected and satisfied with their genetic counseling video encounter, but 
the residual plots constructed from the outcomes’ respective MLRs were as expected for 







- 78 - 
 
Table 24. Perceived Respect and GC Satisfaction 
 







GC Respect  N=93 N=97 N=96 N=286 












 N=93 N=97 N=96 
 
 











Summaries of perceived respect from the genetic counselor and genetic counseling satisfaction scores are 
shown. MLR modeling found no significant differences for these outcomes between the three levels of 
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Figure 14. Frequency Distribution of GC Respect and Satisfaction 
 
 
    Respect 
 
 
   Satisfaction 
 
 
Distribution of the scores for perceived respect from the genetic counselor and genetic counseling 
satisfaction are shown. Both were slightly negatively skewed, but residual plots of the constructed MLR 
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Table 25. Regression Model for GC Satisfaction (N=283) 
 
Model 
R2 = 0.0653 
Coefficients 
β Std. Error p-value 
(Constant) 3.403763 .4914263 0.000 
Genetic Literacy (GLAC) .0910883 .0322799 0.005 
Number of Biological Children .0749928 .0333472 0.025 
Patient-Provider Orientation (PPOS) -.1740556 .0631186 0.006 
Income .0511536 .029231 0.081 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Medium Complexity p = 0.9645 
Family History p = 0.8859 
Marital Status p = 0.6752 
Education p = 0.6702 
Non-Caucasian Race p = 0.5421 
Low Complexity p = 0.4734 
Age p = 0.3916 
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Table 26. Regression Model for Perceived Respect from Genetic Counselor (N=283) 
 
Model 
R2 = 0.0249 
Coefficients 
β Std. Error p-value 
(Constant) 3.26543 .5122456 0.000 
Genetic Literacy (GLAC) .0511046 .0363825 0.161 
Income .0457046 .0336006 0.175 
Number of Biological Children .0555178 .0379062 0.144 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Low Complexity p = 0.9965 
Non-Caucasian Race p = 0.8662 
Marital Status p = 0.8463 
Age p = 0.7499 
Education p = 0.6224 
Patient-Provider Orientation p = 0.4303 
Medium Complexity p = 0.3880 
Perceived Personal Risk of Cancer p = 0.2359 
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Verisimilitude and Engagement Outcomes (Tables 27-30, Figure 15) 
 Verisimilitude was assessed by asking how easy it was for the participants to 
imagine themselves as the client, how real the genetic counselor seemed, and how similar 
the video genetic counseling was to other health care the participant had received. MLR 
with backwards stepwise elimination was used to examine the effect of study arm on the 
participants’ ease of imagining themselves as the client. This analysis showed a 
significant difference in the low complexity group as compared to the high complexity 
group (Table 28). Participants in the low complexity group had similarity scores 0.224 
lower compared to the high complexity group (p=0.012), when the other covariates in the 
MLR, number of biological children, perceived personal risk, were held constant. For the 
measure regarding similarity to other health care, the medium complexity group was 
significantly different from the high complexity group, and participants in the medium 
complexity group reported feeling that the video session was 0.279 points more similar 
compared to those in the high complexity group (p=0.021), when marital status, number 
of biological children, genetic literacy and patient-provider orientation were held constant 
(Table 30). No statistically significant differences were found between complexity groups 
for how realistic the genetic counselor seemed (Tables 28-30).  
In general, participants felt it was easy to imagine themselves as the client, with a 
3.07 average score on a scale from 1 (very difficult) to 4 (very easy). They also felt that 
the genetic counselor seemed between somewhat and moderately real with an average 
score of 2.77 on a scale from 1 (not at all real) to 4 (very real). Table 27 summarizes 
these scores as well as the  frequency of answers for each measure of verisimilitude 
across the three complexity groups. Across all three groups, 6 women reported that it was 
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“very difficult” (1) for ease of imagining themselves as the client (1 high, 0 medium, 3 
low), 17 reported that the counselor seemed “not at all real” (1) (8 high, 4 medium, 5 
low), and 66 reported that the videos were “not at all similar” to other healthcare they 




Table 27. Verisimilitude Score and Count Summaries 
Verisimilitude Response Score Summary 
 







Verisimilitude      






























































*p<0.05, **p<0.01, ***p<0.001 
 
 
Multiple linear regression models were used to detect significant differences between groups, and the low 
complexity group was found to have lower ease scores than the high complexity group controlling for other 
covariates in the model (p=0.088). Participants in the medium complexity group found the video genetic 
counseling experience to be more similar to other healthcare they have had compared to the high 
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Table 27. Verisimilitude Score Count Summaries continued 
 
Verisimilitude Response Count Summary 
 
Ease: Ease of playing role of the client 







 N=92 N=96 N=96 N=284 
Very Difficult 1 (1%) 0 (0%) 5 (5.2%) 6 (2.1%) 
Hard 13 (14.1%) 15 (15.6%) 14 (14.6%) 42 (14.8%) 
Easy 50 (54.3%) 52 (54.2%) 60 (62.5%) 162 (57.0%) 
Very Easy 28 (30.4%) 29 (30.2%) 17 (17.7%) 74 (26.1%) 
 








 N=92 N=96 n=95 N=283 
Not at all real 8 (8.7%) 4 (4.2%) 5 (5.3%)  17 (6.0%) 
Somewhat real 33 (35.9%) 33 (34.4%)  35 (36.8%)  101 (35.7%)  
Real 26 (28.3%)  35 (36.5%)  34 (35.8%) 95 (33.6%)  
Very real 25 (28.2%) 24 (25.0%)  21 (22.1%)  70 (24.7%)  
 








 N=92 N=95 n=94 N=281 
Not at all similar 26 (28.3%)  19 (20.0%)  21 (22.3%)  66 (23.5%)  
Somewhat similar 39 (42.4%)  32 (33.7%)  36 (38.3%)  107 (38.1%)  
Similar 24 (26.1%)  38 (40.0%)  35 (37.2%)  97 (34.5%)  
Very similar 3 (3.3%)  6 (6.3%)  2 (2.1%)  11 (3.9%)  
 
 
Scores for measures of verisimilitude (ease, realism, similarity) are summarized for each complexity level 
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Distribution of the scores for verisimilitude are shown (ease of imagining self as the client, reality of the 
genetic counselor, and similarity to other healthcare). 
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Table 28. Regression Model for Ease of Playing Role of the Client(N=281) 
 
Model 
R2 = 0.0344 
Coefficients 
β Std. Error p-value 
(Constant) 3.390511 .1540349 0.000 
Low Complexity -.2235192 .0880134 0.012 
Number of Biological Children -.0491097 .0340557 0.150 
Perceived Personal Risk of Cancer -.0717508 .049261 0.146 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Genetic Literacy (GLAC) p = 0.9883 
Age p = 0.8782 
Medium Complexity p = 0.8387 
Patient-Provider Orientation p = 0.8382 
Marital Status p = 0.7962 
Income p = 0.5965 
Education p = 0.5663 
Non-Caucasian Race p = 0.5029 
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Table 29. Regression Model for Perceived Reality of Video Genetic Counselor (N=280) 
 
Model 
R2 = 0.0786 
Coefficients 
β Std. Error p-value 
(Constant) 2.456355 .6516473 0.000 
Household Income .0986419 .03885 0.012 
Number of Biological Children .1231756 .0440463 0.006 
Patient-Provider Orientation (PPOS) -.2023654 .0833828 0.016 
Family History .1742183 .1219828 0.154 
Genetic Literacy (GLAC) .0632272 .0430887 0.143 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Perceived Personal Risk of Cancer p = 0.8578 
Marital Status p = 0.7652 
Low Complexity p = 0.7504 
Non-Caucasian Race p = 0.6779 
Medium Complexity p = 0.6213 
Age p = 0.3421 
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Table 30. Regression Model for Similarity to Other Healthcare (N=278) 
 
Model 
R2 = 0.0682 
Coefficients 
β Std. Error p-value 
(Constant) 1.966742 .6349723 0.002 
Medium Complexity .2796464 .1202034 0.021 
Genetic Literacy (GLAC) .0914263 .0411467 0.027 
Number of Biological Children .0856325 .0422025 0.043 
Patient-Provider Orientation -.2221813 .0795998 0.006 
Low Complexity .1696617 .1211165 0.162 
Marital Status -.0703532 .0520976 0.178 
 
Covariates removed by backwards stepwise elimination (p>.20): 
Age p = 0.9837 
Family History p = 0.6590 
Income p = 0.4870 
Perceived Personal Risk of Cancer p = 0.4523 
Education p = 0.4090 
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Engagement (Tables 31-32) 
 When asked how often participants verbally or mentally responded to the genetic 
counselor’s questions, participants tended to report being engaged. Backwards stepwise 
MLR found no significant differences between complexity levels (medium p=0.918; low 
p=0.736 compared to high complexity) when controlling for the included covariates in 
the model, including family history of a first degree relative with breast, ovarian, and/or 
prostate cancer, and genetic literacy (Table 32). Reported engagement averaged 3.62, 
between (3) “about half the time” and (4) “most of the time” on a scale from responding 
verbally or mentally (1) “not at all” to (5) “all of the time”. In all groups, the range of 
engagement across participants covered 1 through 5, indicating that there were 
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Table 31. Self-Reported Engagement Scores and Count Summary 
 
Self-Reported Engagement Scores 
 







Engagement  N=93 N=96 N=96 
 
N=285 











Self-reported engagement scores for each complexity level are shown. Multiple linear regression models 
were used to determine if there were between-group differences, and none were found (Medium p=0.918, 
Low p=0.736). 
 









 N=93 N=96 N=96 N=285 
Not at all 4 (4.3%)  3 (3.1%)  4 (4.2%)  11 (3.9%)  
Some of the time 16 (17.2%)  17 (17.7%)  12 (12.5%)  45 (15.8%)  
About half of the 
time 
15 (16.1%)  14 (14.6%)  19 (19.8%)  48 (16.8%)  
Most of the time 35 (37.6%)  42 (43.8%)  41 (42.7%)  118 (41.4%)  
All of the time 23 (24.7%)  20 (20.8%)  20 (20.8%)  63 (22.1%)  
 
Counts for the number of responses to the question “When the genetic counselor asked you a question, how 
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Figure 16. Frequency Distributions of Self-Reported Engagement 
 
            Engagement 
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Table 32. Regression Model for Engagement (N=282) 
 
Model 
R2 = 0.0308 
Coefficients 
β Std. Error p-value 
(Constant) 1.764727 .7277162 0.016 
Genetic Literacy (GLAC) .1298352 .0520003 0.013 
Family History * .2071823 .1542193 0.180 
* Family History: Having one or more first degree relative with breast, ovarian, and or/prostate cancer.  
 
Covariates removed by backwards stepwise elimination (p>.20): 
Medium Complexity p = 0.9183 
Patient-Provider Orientation p = 0.8544 
Non-Caucasian Race p = 0.8242 
Low Complexity p = 0.7356 
Age p = 0.6696 
Education p = 0.6633 
Marital Status p = 0.6526 
Income p = 0.5956 
Perceived Personal Risk of Cancer p = 0.4732 
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AIM 2: Personal Characteristics and Multivariate Models of Outcomes        
 The purpose of Aim 2 was to examine if clients’ personal characteristics 
(demographics, perceived personal risk of cancer, genetic literacy, and patient-provider 
orientation) were associated with the genetic counseling session outcome measures, and 
whether there were moderating effects of these personal factors on the relationships 
between the complexity level and the outcomes. Bivariate analysis was done to look for 
correlations and directionality of relationships between personal characteristics and 
outcomes (Appendix E). Multiple linear regression models with backwards stepwise 
elimination were constructed to determine which, if any, characteristics were 
significantly associated with outcomes. For the multiple linear regression models, 
reference groups for categorical variables were: high complexity, Caucasian race, and 
having no first degree relative with breast, ovarian, or prostate cancer.  
Decisional Outcomes 
Chi square tests for categorical covariates and multinomial logistic regression 
tests for continuous covariates were used to determine whether personal characteristics 
were significantly associated with genetic test decision. Multinomial logistic regression 
models were created using genetic test decision as the outcome and the personal 
characteristic as the independent variable in individual separate models, with no other 
covariates included in the model. 
(1) Genetic Test Decision 
 Significant differences were detected for participant age, perceived personal risk, 
and patient-provider orientation in the decision to have genetic testing following the 
genetic counseling videos (Table 41). The model predicted that as age increased one year, 
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the odds of choosing “No” over “Yes” was 1.030 greater (β =0.0292, p=0.0). For every 
increase in unit of patient-provider orientation towards a preference for greater patient-
centeredness,, the odds of choosing “Maybe” over “Yes” was 2.016 greater (p=0.022). 
No other personal characteristics were found to be significantly associated with genetic 
test decision. 
(2) Decisional Conflict 
The relationships between participants’ characteristics and outcomes after 
watching the videos were explored in the previously described multivariate models. 
Genetic literacy and perceived personal risk of cancer were the only characteristics that 
met statistical significance in the generated model for decisional conflict (Table 11). For 
genetic literacy, for each increase of one unit of genetic literacy (i.e. from 12 to 13 or 5 to 
6), there was a 0.0810 decrease in decisional conflict score  (p=0.006, N=283, R2=0.0761) 
controlling for the other covariates included in the model. This means that as genetic 
literacy increased, decisional conflict decreased, and thus, those with low literacy tended 
to be more conflicted with their decision. With regard to personal perceived risk, for each 
one unit increase in perceived personal risk of cancer (i.e. “3 - about the same as average” 
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(Maybe vs. Yes) 












Age (N=252)  0.00141 (0.0986) 
p=0.886 







    
Education Level   -0.173 ( 0.116) 
 p=0.136 
0.841 0.00730 (0.159)  
 p=0.963 
1.007 
Household Income  -0.0890 (0.0983) 
p=0.365 
0.915 0.0423 (0.126)  
p=0.737 
1.043 
Marital Status p=0.304 
(chi2) 
    
Biological Children  0.0723  (0.111)  
p=0.513 
1.075 0.118 (0.137)  
p=0.390 
1.125 
Family History** p=0.698 
(chi2) 
    
Personal perceived 
risk of cancer 
 0.382 (0.167) 
p=0.022 
1.47  -0.0852  (0.200) 
p=0.670 
0.918 
GLAC   -0.115 (0.105) 
 p=0.272 





 0.237 (0.214) 
p=0.269 
1.267 0.701 (0.295) 
p=0.017  
2.016 
*Mlogit: Multinomial logistic  
**Family history = having at least one first degree relative with breast, ovarian, and/or prostate cancer. 
 
 
Multiple logistic regression models and chi square tests were performed to detect significant differences 
between test decisions based on continuous personal characteristics. 
For the multiple logistic regression, the reference group was treated as a “Yes” answer to pursuing genetic 
testing. 
Chi-square tests were performed to detect significant differences between test decisions based on 
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Affective Outcomes 
(1) Positive Emotional Response: 
 The model for positive emotion included the statistically significant personal 
characteristics covariates patient-provider orientation (p<0.001) and age (p=0.011) 
(N=283, R2=0.0898) (Table 13). For each increase in unit of genetic literacy, there was a 
0.145 increase in positive emotion score, controlling for the rest of the covariates in the 
model. For patient-provider orientation, one unit increase toward greater preference for 
patient-centered interactions corresponded with a decrease in positive emotion by 0.48, 
controlling for the other covariates in the model. Each increase of one year in age 
corresponded to a 0.015 increase in positive emotion score, controlling for the other 
covariates in the model. More generally, individuals with lower literacy, higher 
preference for patient centered interactions, and younger age tended to report less strong 
positive emotional responses.  
By examining each emotion individually, a more detailed characterization of 
emotional responses was made (Tables 14 and 15). With each one year increase in age, 
there was a 0.0163 increase in reported ease of mind (p=0.014) and a 0.0141 increase in 
reported confidence (p=0.036) with all other covariates held constant (Table 14). This 
suggests older women tended to report stronger positive emotions than younger women. 
For ease of mind, for each level of increase in education completed (i.e. college to 
graduate school), there was a 0.188 decrease in reported ease of mind (p=0.025) holding 
all other covariates constant, indicating that highly educated women had lower levels of 
ease of mind compared to those with less education.  
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Patient-provider orientation was also associated with ease of mind and confidence 
(Tables 14 and 15). For each increase in unit (i.e. 5 to 6) in the PPOS (toward greater 
preference for patient-centered care), there was a decrease of 0.447 in reported ease of 
mind (p=0.002) and a decrease of 0.454 in reported confidence (p=0.001) while holding 
all other covariates constant. This suggests that participants who are more highly oriented 
towards patient-centeredness tended to report feeling less at ease and less confident after 
interacting with the genetic counselor in this study. Genetic literacy was found to be 
positively associated with confidence, such that with each increase in unit of literacy, 
there was a 0.201 increase in reported confidence (p=0.006), suggesting that participants 
with higher genetic literacy tended to feel more confident after the video genetic 
counseling session that those with lower genetic literacy.  
(2) Negative Emotional Response:  
 Regression models were also created for negative emotion as well as each of the 
individual negative emotions on the emotional response measure (Tables 16-20). 
Covariates included in the model negative emotional model that reached significance 
were perceived personal risk for cancer (p=0.005), genetic literacy (p=0.001), along with 
low complexity (p=0.042) (N=283, R2=0.0846) (Table 16). Perceived personal cancer risk 
was positively associated with strength of negative emotions; for each increase in one 
unit of personal perceived risk of cancer (i.e. “3 - about the same as average” to “4 - 
higher than average”), there was a 0.207 increase in the strength of reported negative 
emotions (p=0.005), holding complexity level, genetic literacy, and race constant. 
Genetic literacy was also associated with negative emotional responses, such that 
participants with higher genetic literacy tended to report lower levels of negative 
 
 
- 98 - 
emotions. For each increase of one unit of genetic literacy, there was a decrease of 0.178 
in strength of reported negative emotions (p=0.001), holding complexity level, perceived 
personal risk of cancer, and race constant, indicating that participants with lower genetic 
literacy tended to report stronger negative emotions than those with higher literacy.  
 The MLR model constructed for fear demonstrated statistically significant effects 
of  age (p=0.029), income (p=0.003), and perceived personal risk of cancer 
(p=0.001)(N=283, R2=0.084) (Table 17). Age was negatively associated with fear; with 
each increase in year, reported strength of fear feelings decreased by 0.0139 (p=0.029), 
controlling for personal perceived risk for cancer, education, and income. Income was 
positively associated with fear, such that for each bracket of income increase (i.e. from 
$50,000-$75,000 to $75,000-$100,000), there was a 0.206 increase in the reported 
strength of fear emotional response (p=0.003), controlling for the other variables in the 
model. Perceived personal risk of cancer was also positively associated with fear, such 
that for every unit increase in perceived personal risk, there was a 0.351 increase in  
reported fear (p=0.001).  Although not associated with fear, low genetic literacy was the 
only variable significantly associated with stronger feelings of frustration, such that every 
unit increase in literacy corresponded to a 0.170 decrease in frustration (p=0.019), 
controlling for low complexity in the MLR model for frustration (Table 19).  
The MLR model for the negative emotion feeling “different from others” 
demonstrated a statistically significant relationship with only a single variable, racial 
group (p=0.003), (N=278, R2=0.0696) (Table 20). Non-Caucasian participants reported 
feeling more different from others after watching the videos than did those in the 
Caucasian group. Compared to the Caucasian group, the non-Caucasian group reported  
 
 
- 99 - 
scores on the “different from others” variable that were 0.625 higher than those in the 
Caucasian group, controlling for genetic literacy, complexity, family history, and 
personal perceived risk (p=0.003).  
In addition to differing by study arm, the negative emotion confusion was also 
associated with multiple personal characteristics. The MLR for confusion demonstrated 
statistically significant differences for  genetic literacy (p<0.001) and personal perceived 
risk (p=0.046)(N=283, R2=0.1027) (Table 18). Perceived personal risk was positively 
associated with the feeling of confusion, such that for each unit increase in perceived risk 
for cancer (i.e. “3 - about the same as average” to “4 - higher than average”), there was an 
increase in reported confusion scores of 0.206 (p=0.046), holding other covariates 
constant. Genetic literacy was negatively associated with feelings of confusion; as genetic 
literacy increased by one unit, the strength of feelings of confusion decreased by 0.316 
points (p<0.001), holding the other covariates in the model constant.  
(3) Genetic Counseling Satisfaction and Perceived Respect from the Genetic 
Counselor: 
 Similar to outcomes for emotional response, genetic literacy and patient-provider 
orientation were each associated with satisfaction after the genetic counseling session. 
Statistically significant demographic characteristics in the MLR for satisfaction included 
genetic literacy (p=0.005), number of biological children (p=0.025), and patient-provider 
orientation (p=0.006)(N=283, R2=0.0653) (Table 24). As genetic literacy increased by 
one unit, satisfaction also increased by 0.88 units (p=0.011), indicating that individuals 
with higher genetic literacy tended to be more satisfied. Individuals with a higher patient-
centeredness orientation tended to be less satisfied than those who were more disease- or 
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doctor-centered, as one unit increase on the PPOS was associated with a 0.156 decrease 
in satisfaction (p=0.021). Respect from the genetic counselor did not differ significantly 
across any of the personal characteristics, and the average reported respect was generally 
high (~4 out of 5), as discussed previously (Table 26).  
 
Cognitive Outcomes 
(1) Cancer Genetics Knowledge: 
 Beyond gathering emotional and affective responses, participants were tested on 
their cancer genetics knowledge after watching the videos. The MLR model for 
knowledge included statistically significant covariates genetic literacy (p<0.001), and 
racial group (p<0.001) (N=283, R2=0.2106) (Table 23). The R2 value for this model 
accounts for 21% of the variance in the model, which captures more of the variance than 
the other outcome models. As a group, the non-Caucasian racial group scored 0.949 
lower on the knowledge measure than the Caucasian reference group, while holding the 
other covariates in the model, genetic literacy, patient provider orientation, and income 
constant. Genetic literacy was also associated with cancer genetics knowledge; higher 
genetic literacy was associated with higher scores on the knowledge test. For every unit 
increase in genetic literacy, there was a 0.352 increase in knowledge score, while 
controlling for the rest of the model’s included covariates.  
Verisimilitude 
 In order to gauge how realistic the video session and genetic counselor seemed 
and how easy it was for the participant to play the role of the client, questions were asked 
to address the verisimilitude of the experience. For the MLR model for “ease,” or how 
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easy it was for participants to play the role of the client, no personal characteristics 
included in the model were significantly associated with ease.  
Statistically significant demographic characteristics included in the MLR model 
for perceived reality of the genetic counselor included patient-provider orientation 
(p=0.016), income (p=0.012), and number of biological children (p=0.006) (N=280, 
R2=0.0786) (Table 29). Participants with higher patient-provider scores (PPOS) toward 
more patient-centered orientation felt that the counselor seemed less real than those with 
lower scores. For every point increase on the PPOS, the perceived reality of the video 
genetic counselor decreased by 0.202, controlling for the other covariates in the model. 
Household income and number of biological children were positively associated with 
perceived reality. For each increase in bracket of income, there was an increase of 
perceived reality by 0.0986, and for each added biological child, there was an increase of 
perceived reality of 0.123 controlling for all other covariates in the model in each case.  
Genetic literacy and patient-provider orientation were also associated with how 
similar the participants felt the video genetic counseling session was to other healthcare 
they had received (Table 30). The MLR for the similarity measure included genetic 
literacy (p=0.027), number of biological children (p=0.043), patient-provider orientation 
and (p=0.006) (Table 30). Genetic literacy was positively associated (0.0914 increase in 
similarity for every unit increase of genetic literacy while controlling for all covariates, 
p=0.027, while patient-provider orientation was negatively associated with similarity 
(0.222 decrease in similarity for every unit increase in the PPOS while controlling for all 
other covariates, p=0.006. Number of biological children was positive associated, and for 
each increase of one child, there was a 0.0856 increase in similarity to other healthcare 
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while controlling for the other covariates in the model (p=0.043). 
 
Self-Reported Engagement 
 As a way of approximating how engaged or active participants were in the 
hypothetical genetic counseling session, participants were asked on a scale of 1-5 how 
often they engaged verbally or mentally with the video genetic counselor when she asked 
them a question. The only statistically significant demographic characteristics in the 
MLR model for engagement was genetic literacy (p=0.013) (N=282, R2=0.0308) (Table 
32). For every unit increase in genetic literacy, engagement scores increased 0.129 
(p=0.013) controlling for family history, indicating that individuals with lower literacy 
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AIM 2.1: Personal Characteristics as Modifiers  
 Another aim of this study was to examine not only if personal characteristics were 
associated with genetic counseling outcomes, but if they had a moderating effect on the 
relationship between communication complexity and those outcomes. For the decision to 
have genetic testing, stratified multinomial logistic regressions were run to examine 
differences in effects on testing decision by complexity level. Stratified models were only 
created for the personal characteristics found to be associated with the test decision (age, 
perceived risk of cancer, and patient-provider orientation).  
For affective and cognitive outcomes, stratified regression models by complexity 
level were created to include a single outcome with a single personal characteristic to 
compare the effects of complexity on the relationship between personal characteristics 
and outcomes. Only personal characteristics that were found to have an association with 
those outcomes (as described previously) were used in the stratified models. Multiple 
linear regression models were also created using interaction terms with communication 
complexity. Personal perceived cancer risk, age, race, genetic literacy, patient-provider 
orientation, education, and income were each run individually as interaction terms with 
complexity level in separate multiple linear regression models for each outcome.  
Decisional Outcomes 
 Stratified multinomial logistic regression was used to detect effect modification of 
complexity level on personal characteristic covariates and genetic test decision. Effect 
modification of complexity level on personal characteristics and outcomes were found for 
personal perceived risk of cancer and patient-provider orientation (Tables 33 and 34). 
Within the high complexity group,  the odds of choosing “Maybe” or “No” were not 
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significantly different from the odds of choosing  “Yes” as personal perceived risk of 
cancer increased. However, the odds of non-yes responses vs “yes” responses  did tend to 
vary as personal perceived risk of cancer increased  in the medium and low complexity 
levels. For each unit increase in personal perceived risk of cancer, there was a 2.53 
greater odds of choosing “Maybe” over “Yes” and a 3.43 greater odds of choosing “No” 
over “Yes” in the medium complexity condition (p=0.007 and p=0.009, respectively). In 
the low complexity condition, the odds of choosing “No” vs. the odds of choosing “Yes” 
for every increase in unit of perceived personal risk of cancer was 0.437 lower (p=0.026), 
indicating that in the low complexity condition, individuals with higher perceived 
personal risk were less likely to choose “No” over “Yes.”  
 Effect modification was also present for complexity level on patient provider 
orientation (PPOS) and the genetic test decision. There were no differences in odds of 
choosing “Maybe” or “No” over “Yes” in the high complexity group as PPOS increased, 
but there were differences in the medium and low complexity groups. In the medium 
complexity group, for every increase in unit of the PPOS toward preference for grater 
patient centered interactions, there was a 2.66 greater odds of choosing “No” over “Yes”. 
However, this finding was only marginally statistically significant.  In the low complexity 
group for each unit increase in the PPOS, there was a 2.23 greater odds of choosing 
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Table 34. Multinomial Logistic Regression Models for Personal Characteristics that 
Modify the Effect of Complexity Level on Genetic Test Decision 
 




   
β (SE) p-value Odds Ratio 
  Maybe .1487 (.282) 0.597 - 




   
β (SE) p-value Odds Ratio 
  Maybe .928 (.347) 0.007 2.53 
  No 1.234 (.473) 0.009 3.43 
Low Complexity 
LR chi2(2) = 8.08 
N=95 
   
β (SE) p-value Odds Ratio 
Maybe 0.308 (.289) 0.286 - 
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Table 34. Multinomial Logistic Regression Models for Personal Characteristics that 




LR chi2(2) = 0.17 
N=93 
   
β (SE) p-value Odds Ratio 
  Maybe .166  (.413)  0.687 - 
  No .0174 (.494)  0.972  - 
Medium Complexity 
LR chi2(2) = 4.93 
N=97 
 
   
β (SE) p-value Odds Ratio 
  Maybe .928  (.342)  0.703 - 
  No .981 (.518)  0.058  2.66 
Low Complexity 
LR chi2(2) = 7.39 
N=96 
   
β (SE) p-value Odds Ratio 
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Affective Outcomes 
Genetic literacy was found to modify the relationship between communication 
complexity and satisfaction as well as the relationship between communication 
complexity and respect. Stratified regression model analyses by complexity level were 
performed to detect whether the relationships between genetic literacy and satisfaction 
differed from zero. Regression models including satisfaction and genetic literacy for each 
complexity level found that the changes in satisfaction by genetic literacy were not 
significantly different from zero for the medium and low levels (p=0.922, p=0.211), but 
the regression coefficient was significantly different from zero for the high complexity 
level (p=0.010). For individuals in the high complexity group only, for every unit 
increase in genetic literacy, there was an increase in satisfaction of 0.1632 points, with no 
other variables in the regression model. Thus, individuals with lower genetic literacy 
tended to be less satisfied than those with high genetic literacy only in the high 
communication complexity group.  
Multiple linear regression models for satisfaction including complexity, genetic 
literacy, and the interaction terms between complexity and genetic literacy were 
completed to further explore differences between the groups. As seen in the stratified 
regression analyses, the interaction terms indicated that the relationships between genetic 
literacy and satisfaction differed between the high complexity vs. the medium complexity 
group (p=0.047)Although it was not statistically significant, there was a similar trend 
present comparing the high with the low complexity groups  (p=0.176). 
Stratified regression modeling by complexity level for respect and genetic literacy 
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had a similar trend, with only the high complexity level having a significant relationship. 
The medium and low complexity groups did not show significant relationships between 
genetic literacy and respect (p=0.266 and p=0.326, respectively). In the high complexity 
group, for each increase in unit of genetic literacy, there was a 0.184 increase in respect 
(p=0.002) with no other variables in the regression model. Similar to satisfaction, 
individuals with lower genetic literacy tended to feel less respected by the video genetic 
counselor only in the high complexity group. MLR modeling including interaction terms 
for complexity level together by genetic literacy showed that the relationships between 
genetic literacy and respect tended to differ when comparing the high complexity group 
with the medium complexity group (p=0.004). A similar but non-significant trend was 
seen comparing the high with the low complexity groups with regard to respect 
(p=0.153). 
No other affective outcomes had significant interaction terms, indicating no 












- 109 - 
Figure 17. Best Fit Linear Regression Model of Genetic Literacy and Satisfaction by 
Communication Complexity 
                          









 High  Medium  Low  
  β (SD) p-value  β (SD) p-value  β (SD) p-value 
GLAC 0.1632 
(.0622) 









Table 36. Summary of Genetic Literacy and Interaction Term Effects with 
Communication Complexity on Satisfaction  
 
Genetic Literacy 
Interaction Term Interaction β Coefficient p-value 
Satisfaction*Medium Complexity -0.158 p=0.047 
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Figure 18. Best Fit Linear Regression Model of Genetic Literacy and Respect by 
Communication Complexity 
 




Table 37. Stratified Regression Models for Genetic Literacy and Respect by Complexity 
 
Respect 
 High  Medium  Low  
   β (SD) p-value  β (SD) p-value  β (SD) p-value 
GLAC 0.184 
(0.0588) 










Table 38. Summary of Genetic Literacy and Interaction Term Effects with 
Communication Complexity on Respect  
 
Interaction Term Interaction β Coefficient p-value 
Respect*Medium Complexity -0.26 p=0.004 
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Cognitive Outcomes 
 Cancer genetics knowledge was the only other genetic counseling outcome 
affected by interactions between personal characteristics and complexity level. Stratified 
regression models showed that there was a significant relationship between knowledge 
and PPOS only in the medium complexity group. Individuals with a doctor-centered 
preference (low PPOS) tended to have lower knowledge scores than those with a more 
patient-centered style preference (high PPOS) when assigned to a medium complexity 
genetic counselor (Figure 19). Sensitivity analysis removing the outliers in the medium 
complexity group with the lowest three knowledge scores did not alter this relationship. 
This linear relationship was not seen in the high or low complexity groups, as in those 
groups the relationship between PPOS and knowledge was not significantly different 
from zero (p=0.301 for high, p=0.284 for low complexity).  
 Multiple regression models for  knowledge including PPOS, complexity, and the 
interaction terms between complexity level and PPOS were constructed to examine the 
effects of the interaction term. this showed that the relationship between PPOS and 
knowledge in the medium complexity group was significantly different from that seen in 
the high complexity group (p=0.025). This trend was not observed in the low complexity 
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Figure 19. Best Fit Linear Regression Models of Patient-Provider Orientation and 
Knowledge by Communication Complexity 
 





Table 39. Summary of Patient-Provider Orientation and Complexity Interaction Terms 
 
Interaction Term Interaction β Coefficient (SE) p-value 
PPOS*Medium Complexity 0.847 (.377) p=0.025 




Table 40. Stratified Regression Models for PPOS and Knowledge by Complexity 
 
Knowledge 
 High  Medium  Low  
   β (SD) p-value  β (SD) p-value  β (SD) p-value 
PPOS 0.208 
(0.301)  
   0.490  1.056 
 (0.241)  















 While our study aimed to detect differences in genetic counseling outcomes based 
on the level of complexity of the communication of genetic information, we found that in 
our cohort of 286 women without a personal history of cancer, there were only a few 
major effects of communication complexity alone. We found that in the low complexity 
condition, overall negative emotional response and confusion were felt significantly less 
strongly compared to the high complexity group. While it was encouraging to find that 
lowering complexity also lowered confusion and negative emotional response, we did not 
find that lowering complexity and thus, lowering confusion, improved knowledge scores 
or other outcomes among this group of participants. While participants in the low 
complexity group felt less confused, they did not necessarily learn the information better 
than those in the high complexity group. 
There were no main effects of communication complexity for outcomes of genetic 
test decision, positive emotional response, knowledge, perceived respect, or satisfaction. 
Of note, the medium complexity group, but not the low complexity group, had a 
statistically significantly higher reported level of decisional conflict compared to the high 
complexity level. Decisional conflict relates to the “condition of hesitation and doubt 
about a forthcoming decision” (Katapodi et al., 2011), and in our study, participants 
deliberated about the decision to proceed with genetic testing after having video genetic 
counseling for a hypothetical scenario of having a sister affected with cancer. Participants 
in the medium complexity group were given as much informational detail as the higher 
complexity group (though using more plain, less complex language). The medium 
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complexity group also offered as many turns to speak or to be engaged with the video 
genetic counselor as the low complexity group. In the high complexity level, the genetic 
counselor talked for 21 minutes and had seven opportunities for the participant to engage 
or interact verbally or mentally, while in the medium complexity level, she talked for 18 
minutes and gave 17 opportunities. In the low complexity level, the genetic counselor 
only talked for 12 minutes and also gave 17 opportunities for the participant to have a 
turn to engage. The content of the genetic counseling session across all three arms 
involved aspects of receiving uncertain or uninformative test results.  Hearing the 
detailed information both in a more accessible and more interactive way may have 
created additional conflict in the medium complexity group as they attempted to make 
sense of the nuances of what they heard and to understand the uncertain nature of the 
testing. Contrastingly, the medium complexity condition could have been both an 
overload of information and a burden to remain interactive in the session while also not 
receiving real-time answers to their questions. It is also possible that the combination of 
more detailed information and a perceived burden of being asked to interact with the 
video genetic counselor during the hypothetical medium complexity session  may have 
negatively affected how certain the participants felt about their decision. There were no 
main effects of complexity on the genetic test decision, so participants in this group 
tended to feel slightly more conflicted overall but did not choose one test decision more 
frequently than expected based on responses in the other two study arms. One aspect of 
decisional conflict entails “lacking needed information to make [a] decision” (Katapodi et 
al., 2011). The observation that there was not significantly higher decisional conflict in 
the low complexity group suggests that the information provided was seen to be as 
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sufficient to those participants as was the information presented to the high complexity 
group.   
We hypothesized that higher communication complexity would lead to lower 
satisfaction in genetic counseling and lower perceived respect from the genetic counselor. 
However, those hypotheses were not supported. We also predicted that those in the 
higher complexity group would perform more poorly on the knowledge measure and that 
they would report being less engaged, which were also not supported. Participants 
generally had the same satisfaction, perceived respect, cancer genetics knowledge, 
emotional responses (besides negative emotion and confusion), engagement, and made 
the same testing decisions (and felt the same way about them), across the three 
communication complexity levels.  
These findings were unexpected as research in medical and genetic counseling 
communication would suggest that lowering communication complexity and increasing 
interactivity would improve affective and cognitive outcomes. In one study in which 
subjects watched videos of simulated genetic counseling sessions from the GCVP and 
were told to imagine themselves as the client, individuals with restricted literacy (under 
the 8th grade level) benefited from and learned more in sessions with “greater dialogue 
interactivity and more personally contextualized information” (Roter et al., 2009). In the 
same study, they found that individuals with higher literacy did not see the same benefit, 
which is in line with our study’s findings in our highly literate population. Studies in 
adult learning theory suggest that active learning and personal relevance benefit learning 
for all individuals, so we would have expected elements such as teach-back, using “you” 
statements, information chunking, and interactivity that engaged the participant to 
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enhance learning (Knowles, 2011; Doak et al., 1996). Our particular cohort was well-
educated and had relatively high levels of genetic literacy, so we may not have been able 
to detect benefits of lowering complexity without a larger number of participants with 
lower literacy levels.  
A study that assessed oral literacy demand in genetic counseling dialogue found 
that simulated clients were less satisfied with genetic counseling session communication 
when more technical terms were used, and dialogue was more dense and less interactive 
(Roter et al., 2007). The genetic counseling outcomes of satisfaction and respect have 
been traditionally high in genetic counseling outcome studies with real clients (Veach et 
al., 1999; Shiloh et al., 1990).  However, although both outcomes were negatively 
skewed in our dataset, we had sufficient variability that we expected to see some 
differences across complexity levels. However, our study population was different in that 
they only received one session of genetic counseling, whereas the simulated clients in the 
Roter study experienced multiple sessions and were able to compare the sessions in ways 
that our participants could not. 
As genetic testing and technologies continues to evolve, genetic counselors are 
also adapting their clinical practice, and there is evidence that cancer genetic counselors 
are moving to “[trade] depth of information for breadth” which may involve losing 
informational details (Hooker et al., 2017). In our study, those assigned to the lower 
complexity performed just as well, indicating that using more accessible language and 
more interactivity did not lead to lack of informed decision-making, frustration, or other 
negative outcomes in this group of relatively well-educated research participants. Of 
note, low communication complexity was not associated with decreased satisfaction with 
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care, perceived respect, positive emotional responses, knowledge, or increased decisional 
conflict. If genetic counselors are spending the majority of their time communicating 
genetics and biomedical information to their patients and clients, nothing appears to be 
objectively gained from providing that information in a complex way.  
 
Relevance of Personal Characteristics 
 Regardless of communication complexity, participants’ personal characteristics 
were associated with a number of our measured genetic counseling outcomes. In 
particular, the personal characteristics of genetic literacy, perceived personal cancer risk, 
and patient-provider orientation had significant relationships with the many of the 
measured outcomes. For decisional outcomes, older women and women who preferred 
more patient-centered interactions were slightly more likely to choose “No” over “Yes”. 
This may have been due to a number of factors including being beyond reproductive age 
and living past much of the hypothetical risk of early-onset breast and ovarian cancer. 
Additionally, women with higher perceived personal risk for cancer were slightly more 
likely to choose “Maybe” over “Yes”. Women with higher perceived personal risk of 
cancer also had higher decisional conflict, suggesting that their personal risk perceptions 
were impacting their test decisions as well as how they felt about that decision.  
 Emotional response was impacted by personal characteristics as well. Overall, 
older women tended to report feeling positive emotions after the session more strongly 
than did younger women. The qualitative data collected may provide context for this 
finding and whether older women felt that the session was more useful for themselves or 
their family members, or perhaps that they enjoyed the educational aspects of the videos, 
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or that they did not find the information particularly threatening to their own health. On 
the other hand, women with lower genetic literacy tended to report poorer emotional 
outcomes. They reported feeling positive emotions less strongly and also reported 
stronger negative emotional responses following the video genetic counseling session. 
This association between lower genetic literacy and poorer emotional response has been 
observed in the oncology setting in a study examining the link between emotional 
response and health literacy in women at risk for cervical cancer (Sharp et al., 2002).  
Another participant group that felt less positively afterward viewing the sessions 
were women reporting a higher preference for patient-centered care. This finding may 
suggest that the hypothetical genetic counseling experience was not viewed as patient-
centered due to absence of true two-way, adaptable communication. Though positive 
emotion is distinct from satisfaction, this finding is aligned with research that has shown 
that incongruence between the provider’s patient-provider orientation and the patient’s 
orientation can lead to patient dissatisfaction (Krupat et al., 2000). In the specific 
negative emotional response of “feeling different from others,” non-Caucasian race was 
the only personal characteristic related to higher scores of feeling different, compared to 
Caucasian participants. Reasons for this could include elements of being presented with 
unfamiliar information by a genetic counselor of discordant race. However, race was not 
significantly negatively associated with the verisimilitude component “similarity to other 
healthcare,” so non-Caucasian participants did not feel that the genetic counseling session 
was more dissimilar to care they had received in the past compared to the Caucasian 
women in the study.  
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 After the video genetic counseling session, participants were given a cancer-
genetics knowledge test. Genetic literacy and race were both related to knowledge scores. 
Individuals with lower genetic literacy tended to score more poorly on the knowledge 
measure. While the GLAC is a measure that approximates genetic literacy through 
assessment of familiarity with genetics certain terms, the cancer genetics knowledge 
measure is more specific to factual content that was introduced in the genetic counseling 
session that has been considered to be relevant to cancer genetic counseling. Though the 
GLAC and the knowledge test are separate measures, we expected the two be related as 
we would expect familiarity with genetics terminology to affect how readily one might 
gain new knowledge about cancer genetics. Beyond genetic literacy, individuals of Non-
Caucasian race also performed more poorly on the knowledge test. In our cohort, the 
bivariate analysis showed that Non-Caucasian race was associated with lower GLAC 
scores as well as lower educational level and income, so the effects of race in this 
instance may be muddled by the group having lower genetic literacy overall. Of note, 
educational level was not found to be a significant predictor of cancer genetics 
knowledge, suggesting that genetic literacy and comfort with genetic-specific information 
were a better indicator of how well someone could learn from our genetic counseling 
sessions than educational level in our cohort.  
 Genetic counseling satisfaction was related to genetic literacy, patient-provider 
orientation, and the number of biological children. Having a lower genetic literacy was 
associated with lower satisfaction in the genetic counseling session, which was expected 
based on what is known about limited health literacy and lower satisfaction more 
generally in medical communication research (Jensen et al., 2010; MacLeod et al., 2017). 
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Individuals with higher PPOS scores were also less satisfied. Those with a preference for 
patient-centered style of care and communication may have not felt that their needs or 
expectations were fulfilled (as was observed in their less positive emotional responses), 
especially in this study context lacking true interaction. Interestingly, as the number of 
biological children increased, so did satisfaction. It is possible that this is related to 
women with more children finding the information to be useful for their children, beyond 
personal utility, leaving them to be more satisfied with the encounter. Open-ended answer 
data from our study may help elucidate specific opinions and feelings expressed by 
women with a higher number of children.  
Interaction Effects between Complexity and Personal Characteristics 
We also hypothesized that genetic literacy, patient-provider orientation, and 
personal perceived risk for cancer would moderate the effects of communication 
complexity on study outcomes. We found this to be true in the case of genetic literacy 
and patient-provider orientation, but not for perceived personal risk of cancer. There was 
a statistically significant relationship between genetic literacy and respect as well as 
genetic literacy and satisfaction in the high complexity condition but not in the medium 
or low complexity conditions. Individuals with lower genetic literacy tended to report 
lower satisfaction and lower perceived respect from the genetic counselor in the high 
complexity group. The genetic counseling satisfaction measure captures aspects of 
service quality which have short-term implications for care. Beyond the short-term 
effects, satisfaction has been suggested to related to the development of a therapeutic 
relationship and has been shown to enhance adherence to subsequent medical 
recommendations, both of which have implications for health outcomes (Street et al., 
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2009; Ong et al., 2000). By capturing the short-term satisfaction, and by identifying 
instances in which satisfaction is reduced (or increased), interventions can be designed to 
not only improve satisfaction, but also to enhance health. Perceived respect from the 
genetic counselor can be viewed in a similar way and  has similarly been associated in 
other medical contexts with longer term outcomes such as adherence (Beach et al., 2005). 
Individuals with lower literacy reported feeling less respected in the high complexity 
condition than did those with higher literacy. While our study detected effect 
modification of genetic literacy on complexity level for these two outcomes, a stronger 
effect might be detected in a cohort with more diversity in terms of genetic literacy, 
including individuals with much lower literacy levels. 
Aside from satisfaction and respect, the effect of complexity level on knowledge 
was modified by the personal characteristic of patient-provider orientation such that a 
relationship was only observed in the medium complexity condition. In the medium 
complexity condition, as PPOS increased, so did knowledge scores. In this arm, 
individuals who preferred a more doctor-centered communication style demonstrated 
lower knowledge scores than those who preferred a patient-centered style. Individuals 
with lower PPOS scores prefer their providers to be the sole providers of information, to 
have less focus on emotional aspects of care and more on the problem or reason for 
medical visit, and to share more of the responsibility for decision-making in the session. 
The medium condition videos were designed to include as much factual detail as the high 
complexity, but using more plain language and utilizing more turn taking and 
interactivity. The medium complexity perhaps posed the greatest learning challenge 
through the combination of less accessible language presented in a non-preferred less 
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direct communication style.  Perhaps the interactive aspects interfered with individuals’ 
ability to take in the information presented. This pattern was not observed in either the 
high complexity nor the low complexity groups. Perhaps the more direct communication 
style in the high complexity condition (without much interaction) worked better when the 
information itself was highly complex and detailed for the subset of individuals who 
preferred a more doctor-centered approach. It is interesting to note that participants with 
similar preferences for doctor-centered communication did not have lower knowledge 
scores than others when assigned to a communication style that was more interactive 
when the information was also presented in a less complex manner, as in the low 
complexity condition. Again, analysis of the open-ended data collected will be useful in 
further characterizing and qualifying these patterns. Our participants had a range of PPOS 
scores, and gaining a better understanding of how PPOS contributes to learning within 
medical care will have important clinical implications. While there is evidence that 
discordance between patient and provider in PPOS can be detrimental to satisfaction, less 
is known about how discordance affects learning and longer-term health outcomes 
(Krupat et al., 2000). 
Verisimilitude and Reported Engagement 
Our study was unlike typical clinical genetic counseling care in several ways—it 
used a hypothetical scenario with analogue clients, involved video genetic counseling, 
was not truly interactive, and the genetic counselor did not adapt to verbal or mental 
responses from the participants. Verisimilitude scores for our study indicated that, despite 
these challenges, the majority (83%) of participants found it easy or very easy to play the 
role of the client and a slight majority (58%) found the genetic counselor to be realistic or 
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very realistic. The average score for similarity to other healthcare was between 
“somewhat similar” and “similar”. This similarity score was not surprising as genetic 
counseling is a unique medical specialty in which a provider may explain many options 
and choices (including benefits and downsides), and often leaves the decision up to the 
client rather than instructing what should be done (in the absence of professional medical 
guidelines). The video aspect of the genetic counselor combined with the standardized 
nature of the interaction without feedback likely contributed to lower scores of 
verisimilitude, but despite these challenges, verisimilitude scores indicated this was a 
realistic experience for the participants across all three groups.  
  While the one-way nature of the video genetic counseling session was likely a 
barrier to engagement, it was encouraging to note that participants reported verbally or 
mentally engaging more often than not. As hypothesized, individuals with lower genetic 
literacy reported being less engaged with the video genetic counselor than those with 
higher genetic literacy. This pattern has been observed in other studies in which 
individuals with limited health literacy asked fewer questions and were less engaged in 
real healthcare settings (Doak et al., 1996). Though “engagement” in our study more 
closely resembled adhering to the requested tasks of the study (i.e. answering questions 
and responding), recording active engagement level and quality could be the target of 
further study, to determine how patient engagement varies when provider communication 
varies in complexity. 
Participants who completed our study (N=286) invested time and energy into not 
only answering the survey questions, but also providing written responses to open-ended 
study questions. The relatively high scores in reality, ease, and reported engagement 
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suggest that this model of experimentation can be useful in gathering affective, cognitive, 
and written responses from participants, and that it can be a useful way of manipulating 
aspects of communication of information as well as individual aspects of communication 
such as empathic statements or elements of non-verbal communication that would be 




 Beyond the quantitative results described, qualitative analysis of the open-ended 
answers gathered will provide context and depth. Though main effects  of language 
complexity were not found with regard to most outcomes, additional insights may be 
gained from the qualitative data about how participants viewed the different experience. 
Additionally, any evidence of discordant answers between individuals in our cohort (i.e. 
one prefers to hear statistics whereas another finds statistics information least useful) 
would support the need for tailored communication of information in genetic counseling. 
Future analysis will aim to make connections between themes and concepts found in the 
open-ended questions and relate them to the quantitative data across complexity levels 
and different personal characteristics.  
 
Limitations 
By only focusing on manipulation of communication complexity, we did not 
capture elements of a genetic counseling appointment that involve the development of a 
therapeutic relationship. Providing education in the context of a therapeutic relationship 
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could have altered the observed effects.,  The nature of the relationship between client 
and genetic counselor can affect learning and knowledge outcomes as patients make 
meaning of the information they hear, (Street et al., 2009). Relationship building also 
involves building trust, and altering elements that impact the therapeutic relationship 
would also likely impact outcomes of satisfaction and perceived respect. We were not 
able to capture different approaches to teaching by involving visual aids or written 
material to reinforce what was being said by the genetic counselor. These learning aids, 
including graphs of risks, tables of gene names, and pictures of genetic material (DNA, 
genes, chromosomes) are often present in genetic counseling practice. Our participants 
may have been limited in what they were able to learn and remember by not seeing or 
reading media that emphasized the information presented by the genetic counselor. 
Though our study utilized a unique experimental design that was able to 
standardize language and communication and reach many participants, it could not fully 
emulate an in-person or real-time genetic counseling session. Despite incorporating 
elements of interactivity and person-focused language, the video counseling was not able 
to tailor information to the participant. The video genetic counselor could neither skip 
over information that participants were already familiar with nor could she repeat, 
reframe, or slow down the information that she was communicating. 
Another limitation was that our participant population was highly educated, 
highly familiar with genetics, and the majority were Caucasian. A brief overview of the 
open-ended data indicated that at least a few individuals noted that they worked in a 
medical or genetics field (as many CRVP participants are themselves NIH employees or 
trainees). There may have been a ceiling effect of genetic literacy present in this cohort. 
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We also had a large proportion of women past reproductive age who were older than the 
hypothetical client, which may have impacted the generalizability of the findings. 
However, older women did not report significantly lower levels of ease of playing the 
role of the client. Though our results indicate that most of the participants found it easy to 
imagine themselves as the client, decision-making under a personally threatening 
situation has been shown to impact learning and retention of information (Heilman et al., 
2010), so more work will need to be done to characterize the effects we found in other 
settings and in the clinic. 
Logistically, completing the study was designed to take 30-45 minutes, but some 
participants took over an hour, and comments in the open-ended questions indicated that 
there were too many videos and that it was hard to pay attention. Combined with the 
relatively low response completion rate, the study sample could be subject to bias. A 
shorter design with a narrower scope might make the study less tedious for participants, 
but the trade-off would likely mean only capturing a portion of genetic counseling 
communication, rather than attempting to capturing all of the communication of 
information a client might receive.   
 
Clinical Implications 
 This study aimed to better understand how complexity of information 
communication impacts clients receiving genetic counseling in a hypothetical setting, 
drawing from adult learning theory and oral literacy demand principles as guides for 
emulating levels of high, medium, and low complexity experimentally. Though genetic 
counseling practice and communication of information is not standardized, the concept of 
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tailoring information in a way that is accessible to patient needs is universal in medicine 
and genetics. For our educated and genetic literate population, complexity did not have 
large main effects. In general, the outcomes of our study, including high levels of 
satisfaction and respect, and low levels of decisional conflict and negative emotional 
response mirror previous outcome studies of genetic counseling (Veach et al., 1999; 
Shiloh et al., 1990; Christie et al., 2012).  
 Our results support the notion that certain patient characteristics contribute to 
genetic counseling outcomes, and while those characteristics cannot be assumed to be 
deterministic, awareness of differential outcomes is important for clinical care. 
Unfamiliarity with genetics and low genetic literacy contribute to poorer genetic 
counseling outcomes, and extrapolating the trends of our findings, it would follow that 
patients with lower literacy levels than we observed would have poorer outcomes. Thus, 
evidence-based interventions designed for assessing and addressing genetic literacy to 
promote learning and understanding are warranted. Personal perceived risk for cancer 
(beyond reported family history of cancer) and patient-provider orientation also 
contribute to differential genetic counseling outcomes. Interventions designed to capture 
and address these concepts within or before the genetic counseling session could, in the 
context of adult learning theories, help promote more positive outcomes as well.  
 While genetics health professionals are well versed in the complex language of 
medical genetics, there is no obvious benefit in presenting information to patients in a 
complex way. While higher complexity language and genetics jargon may suit some 
patients who request additional detail or come into the appointment with a background in 
science and genetics, it may not be broadly successful, leaving patients with lower 
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literacy feeling less satisfied, less respected, and less engaged in their healthcare. 
Counselor-level interventions could benefit patient-provider communication by 
challenging counselors to practice and implement lower complexity language that is most 
relevant and useful for patients. 
 
Future Research 
While the impact of language complexity may not have been large in our cohort, 
research in more diverse populations is necessary, particularly in individuals with genetic 
literacy that is more representative of the general population. The interaction effects 
observed in our study suggest that complexity may have more profound implications for 
populations with more limited genetic literacy.  The current study could be repeated, 
using the same video genetic counseling models, in a targeted population selected for 
lower literacy to better understand the impacts of complexity more broadly and to make 
comparisons with those with higher genetic literacy. Additionally, our cohort included 
only women and a hypothetical scenario. Emotional burden and stress can play into how 
individuals learn and make decisions (Heilman et al., 2010; Vogel et al., 2016), and there 
may be differences between hypothetical clients, unaffected individuals with an affected 
family member, and affected individuals. More research needs to be done on the impact 
of communication complexity in clinical populations, as well as in both men and women 
of all ages. Such a study would require experimentally manipulating genetic counseling 
practice style in actual healthcare contexts.  Though our study only captured immediate 
post-counseling outcomes, more research is necessary to understand if and how 
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communication and short-term outcomes correlate with long-term outcomes including 
emotional well-being, adherence to medical recommendations, and health outcomes. 
Other study designs could be used to test clinical interventions for genetic 
counselors that promote interactivity and turn taking, adult learning theories, and 
lowering oral literacy demand and subsequently measuring post-counseling clinical 
patient outcomes similar to those that were measured here. Another way of capturing the 
effects of complexity of communication of information could be to randomize genetic 
counseling patients to watch different levels of complexity of the same information prior 
to attending a genetic counseling session, and assessing the kinds of questions and quality 
of communication they have within the session after receiving a genetics lesson from the 
video. The video setup allows for easy manipulation of multiple aspects of 
communication, and many iterations and combinations of adjusting complexity 
components (i.e. teach back, turn taking, plain language, and information chunking) 
could be utilized to gain a more detailed understanding of the impact of specific changes 
in communication.  
Communication of information is only one aspect of genetic counseling, though it 
is often the central component and the focus of genetic counseling sessions (Meiser et al., 
2008; Roter et al., 2006). In our study, communication complexity did not affect most of 
our outcomes of interest. In addition to exploring other designs that might allow further 
understanding of the role of complexity, future research should also be done to examine 
if and which counseling aspects of genetic counseling (empathic statements, therapeutic 
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As the field of genetics continues to expand, more and more individuals will have 
access to genetic testing and genetic services. In order to adapt to the increase in demand, 
alternative service delivery models (including video or tele-counseling and education) is 
likely to become more widespread. Additional research will need to be done to assess 
how to best communicate information deemed important to the widest audience. Studies 
such as this one can help clarify how to promote learning and decision making in patients 
before those delivery models become more prevalent. 
 
Conclusions 
 The results from our experimental video genetic counseling communication study 
suggest that though communication complexity did not have large main effects on genetic 
counseling outcomes in our study population (beyond reducing negative emotional 
response and confusion), participants assigned to lower complexity communication did 
not have outcomes that were significantly worse than those assigned to  higher 
complexity communication. Personal characteristics, such as genetic literacy, patient-
provider orientation, and perceived risk of cancer (among other demographic traits) were 
associated with differential decisional, affective, and cognitive outcomes as hypothesized 
based on previous work both within and outside of the genetic counseling context. In 
addition, the observed interaction effects underscore that language complexity may lead 
to differential outcomes among subsets of hypothetical genetic counseling clients. These 
differences reinforce the need for personally tailored communication as well as the need 
to implement targeted interventions to enhance communication, learning, and short- and 
long-term emotional and medical wellbeing. More research is needed in populations 
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representative of the patients that have genetic counseling to further characterize the 
effects of communication complexity and personal characteristics on outcomes to guide 
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APPENDIX A: Study Recruitment Emails 
 
CRVP Recruitment email: ResearchMatch Recruitment email: 
 
Hello Potential Research Volunteer: 
 
Previously, you contacted the NIH Clinical Research Volunteer Program (CRVP) for information about 
healthy volunteer studies. Because you gave permission to be in our volunteer pool, we want to make you 




How do people respond to information about genetics? 
 
Researchers at the National Institutes of Health (NIH) seek women volunteers, 18 years of age or older, 
who have no personal history of cancer (other than basal cell skin cancer) but do have a family history of 
cancer in a first or second degree relative to participate in a study researching how people respond to 
communication about genetic information. 
  
Study Procedures Include: 
-       Collecting demographic information 
-       Viewing online videos 
-       Taking surveys 
-       Talking on the phone with a researcher about the study 
  
Do you qualify? 
-       Are a woman age 18 or older 
-       Are fluent in reading and communicating in English 
-       Have at least one family member who has had cancer (excluding skin cancer) 
-       Family member cannot be a sister who has had breast cancer 
-       Have no personal history of cancer (excluding basal cell skin cancer) 
-       Have access to a computer with an internet connection 
-       Have never had genetic counseling 
  
Location: This study will be conducted through a secure website and over the phone, and participation in 
the study will not require travel to the NIH campus. 
  
Compensation: Participants will be compensated with a $10 Amazon gift card after completion of the 
study. 
  
If you are interested in participating: Please contact emily.bonkowski@nih.gov to set up a time to 
complete the study. 
 
OR (alternative email with link):  
If you are interested in participating: Please proceed to the following link to proceed:  
http://jhsph.co1.qualtrics.com/jfe/form/SV_byAQp9fQmjYuFNz 
 
ResearchMatch Recruitment email: 
 
Hello Potential Research Volunteer: 
  
Previously, you contacted ResearchMatch for information about volunteer studies. Because you gave 
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Volunteers Needed 
  
How do people respond to information about genetics? 
  
Researchers at the National Institutes of Health (NIH) and Johns Hopkins University seek women 
volunteers, 18 years of age or older, who have no personal history of cancer (other than basal cell skin 
cancer) but do have a family history of cancer in a first or second degree relative to participate in a study 
researching how people respond to communication about genetic information. 
  
Study Procedures Include: 
-       Collecting demographic information 
-       Viewing online videos 
-       Taking surveys 
  
Do you qualify? 
-       Are a woman age 18 or older 
-       Are fluent in reading and communicating in English 
-       Have at least one family member who has had cancer (excluding skin cancer) 
-       Family member cannot be a sister who has had breast cancer 
-       Have no personal history of cancer (excluding basal cell skin cancer) 
-       Have access to a computer with an internet connection 
-       Have never had genetic counseling 
  
Location: This study will be conducted through a secure website, and participation in the study will not 
require travel. 
  
Compensation: Participants will be compensated with a $10 Amazon gift card a few days after completion 
of the study. 
 
If you have already participated in this study, you will not be eligible to participate again.  
  
Questions: Please do not reply to this email, but contact Emily Bonkowski directly at 
emily.bonkowski@nih.gov if you have any questions about participation. 
 




Thank you for your interest in our study about the communication of genetic information. If you are still 




The study is set up to be done entirely on the website above, and requires access to a computer with video 
and audio capabilities. The study should take about 30-45 minutes to finish. 
 






ScM Candidate in Genetic Counseling ‘18 
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APPENDIX B: Online Informed Consent Form 
Thesis Survey (Qualtrics form) 
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APPENDIX C: Study Instrument 
 
Q77 Thank you for agreeing to participate in our study. Please confirm that you are eligible for the study by 
confirming that the following statements are all true: 
     I am a woman over the age of 18.   
I can fluently read and communicate in English.   
Someone in my family has had cancer.    
I have never had cancer (except basal cell skin cancer).   
I do not have a sister who has had breast or ovarian cancer.   
I have never had genetic counseling.   
o Yes, all statements are true for me.    





Q78 Please certify that you are a human.  
 
End of Block: Consent Digital/Human Verification 
 
 
Start of Block: Demographics 
 





Q4 What is your racial background? 
o Caucasian    
o African American    
o Asian or Pacific Islander    
o American Indian or Alaska Native    
o Other    
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Q5 What is your ethnic background? 
o Hispanic or Latina    




Q6 What is the highest degree or level of education you have completed? 
o Less than high school    
o High school graduate (includes High School equivalency)    
o Some college, no degree    
o Associate's degree    
o Bachelor's degree    




Q7 What is your annual household income? 
o Under $25,000    
o $25,000-50,000    
o $50,000-75,000    
o $75,000-100,000    




Q8 What is your marital status? 
o Single    
o Married    
o Divorced    
o Widowed    




- 139 - 
 
 
Q9 How many biological children do you have? 
▼  0  ... 10+ (11) 
 
End of Block: Demographics 
 
Start of Block: Family History 
 
Q17 Please select the appropriate number for how many of the listed female relatives have had cancer in 
your family.  
 
 
Some numbers may not apply to the family member.  
 Breast and/or Ovarian Cancer Other Cancer(s) 
 0  1  2  
3 or 
more  




Mother   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Sister(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Daughter(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Grandmother(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Aunt(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Niece(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Female cousin(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  





















Some numbers may not apply to the family member.  
 Male Breast Cancer Prostate Cancer Other Cancer(s) 
 0  1  2  
3 or 
more  
N/A  0  1  2  
3 or 
more  




Father   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Brother(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Son(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Grandfather
(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Uncle(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Nephew(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
Male 
cousin(s)   ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  ▢  
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Q24 What do you think is your risk of getting cancer? 
o Much lower than average    
o Lower than average    
o About the same as average    
o Higher than average    
o Much higher than average    
 
End of Block: Family History 
 
Start of Block: GLAC 
 
 
Q26 The words below are words that patients in the genetics clinic sometimes struggle with. The first 
question after the word asks how familiar you are with each word. Marking “1” on the scale reflects that 
you strongly disagree, marking “7” on the scale means that you strongly agree. Please circle the number 








I am familiar with this term 
o Strongly disagree 1    
o 2    
o 3    
o 4    
o 5    
o 6    
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Q28 Genetics is the study of how living things receive common traits from previous __________. 
o generations    
o experiences    
o exposures    

















I am familiar with this term 
o Strongly disagree 1    
o 2    
o 3    
o 4    
o 5    
o 6    
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Q30 A chromosome contains all of our ________ material.  
o genetic    
o digestive    
o cellular    






I am familiar with this term 
o Strongly disagree 1    
o 2    
o 3    
o 4    
o 5    
o 6    




Q32 Susceptibility to a disease means you __________ get the disease. 
o eventually will    
o definitely    
o might    









I am familiar with this term 
o Strongly disagree 1    
o 2    
o 3    
o 4    
o 5    
o 6    




Q34 A mutation is a change in your _______.  
o intestine    
o skin    
o DNA    












- 145 - 
 
I am familiar with this term 
o Strongly disagree 1    
o 2    
o 3    
o 4    
o 5    
o 6    




Q36 Having variation in the genetic code will lead to disease _________. 
o all of the time    
o some of the time    
o never    






I am familiar with this term 
o Strongly disagree 1    
o 2    
o 3    
o 4    
o 5    
o 6    
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Q38 __________ is an abnormality.  
o A trachea    
o Brown hair    
o Trisomy    






I am familiar with this term 
o Strongly disagree1    
o 2    
o 3    
o 4    
o 5    
o 6    
o Strongly agree7    
 
 
Q40 Heredity is the transfer of characteristics from ___________.  
o the environment to the person    
o the sick to the healthy    
o parent to child    
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I am familiar with this term 
o Strongly disagree1    
o 2    
o 3    
o 4    
o 5    
o 6    




Q42 A genetic disease that occurs without _________ is considered sporadic. 
o symptoms    
o a family history    
o a diagnosis    
o medication    
 
End of Block: GLAC 
 
Start of Block: PPOS 
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The health care 
provider is the one 
who should decide 
what gets talked about 
during a visit.   
o  o  o  o  o  o  o  
Although health care 
is less personal these 
days, this is a small 
price to pay for 
medical advances.   
o  o  o  o  o  o  o  
The most important 
part of the standard 
medical visit is the 
physical exam.    
o  o  o  o  o  o  o  
It is often best for 
patients if they do not 
have a full explanation 
of their medical 
condition.    
o  o  o  o  o  o  o  
Patients should rely on 
their health care 
providers’ knowledge 
and not try to find out 
about their conditions 
on their own.   
o  o  o  o  o  o  o  
When health care 
providers ask a lot of 
questions about a 
patient’s background, 
they are prying too 
much into personal 
matters.   
o  o  o  o  o  o  o  
If health care 
providers are truly 
good at diagnosis and 
treatment, the way 
they relate to patients 
is not that important.   
o  o  o  o  o  o  o  
Many patients 
continue asking 
questions even though 
they are not learning 
anything new. (8)  
o  o  o  o  o  o  o  
Patients should be 
treated as if they were 
partners with the 
health care provider, 
equal in power and 
status. (9)  
o  o  o  o  o  o  o  
Q43 Please select how strongly you agree or disagree with each of the following statements: 
 
 




















their health.    
o  o  o  o  o  o  o  
If a health care 
provider’s primary 
tools are being open 
and warm, the 
health care provider 
will not have a lot 
of success.   
o  o  o  o  o  o  o  
When patients 
disagree with their 
health care 
provider, this is a 
sign that the doctor 
does not have the 
patient’s respect 
and trust.   
o  o  o  o  o  o  o  
A treatment plan 
cannot succeed if it 
is in conflict with a 
patient’s lifestyle or 
values.    
o  o  o  o  o  o  o  
Most patients want 
to get in and out of 
the health care 
provider’s office as 
quickly as possible.   
o  o  o  o  o  o  o  
The patient must 
always be aware 
that the health care 
provider is in 
charge.    
o  o  o  o  o  o  o  
It is not that 
important to know a 
patient’s culture 
and background in 
order to treat the 
person’s illness.    
o  o  o  o  o  o  o  
Humor is a major 
ingredient in the 
health care 
provider’s 
treatment of the 
patient.  (8)  
o  o  o  o  o  o  o  
When patients look 
up medical 
information on their 
own, this usually 
confuses more than 
it helps. (9)  
o  o  o  o  o  o  o  
 
 
End of Block: PPOS 
 
Start of Block: Scenario 








Q73 Please consider the following hypothetical scenario: 
Imagine that you have a sister and that she was recently diagnosed with invasive breast cancer at the age of 
39. She suggested that you meet with a genetic counselor about your risk for breast cancer, and an optional 
genetic test that could be available to you if you were interested. Today, you’ll be watching videos that 
represent what genetic counseling sessions might look like, and you’ll be asked a series of questions about 
your thoughts, feelings, and experiences overall after viewing the videos. 
The genetic counselor may also ask you questions during the session. While we won’t be recording your 
responses to those questions, in order to enhance the reality of the videos, please respond when the genetic 
counselor poses a question (out loud or in your head). Please answer the questions as if this were a real 








[See Appendix D for video scripts] 
 
Start of Block: Test Yes/No 
 
Q45 If you were the client seeing this genetic counselor, would you want to have genetic testing today?  
o Yes    
o Maybe    
o No    
 
End of Block: Test Yes/No 
 
Start of Block: Emotional Response, Decisional Conflict 
 
 










 1  
2  3  
Somewhat 
 4  
5  6  
Very 
Much 7  
Fear   o  o  o  o  o  o  o  
Ease of 
Mind   o  o  o  o  o  o  o  
Confusion   o  o  o  o  o  o  o  
Confidence   o  o  o  o  o  o  o  
Frustration   o  o  o  o  o  o  o  
Different 
from Others   o  o  o  o  o  o  o  
 
Q47 If you were the person seeing this genetic counselor, how much of the following emotions do you imagine 
you might feel after the session ended? Marking “7” on the scale means that you feel that particular emotion 















































This decision is 
easy for me to 
make.   
o  o  o  o  o  
I’m unsure 
what to do in 
this decision.   
o  o  o  o  o  
It’s clear what 
choice is best 
for me.   
o  o  o  o  o  
I’m aware of 
the choices I 
have.   
o  o  o  o  o  
I feel I know 
the benefits of 
my decision.   
o  o  o  o  o  
I feel like I 
know the side 
effects of my 
decision.   
o  o  o  o  o  
I know how 
important the 
benefits are to 
me in this 
decision   
o  o  o  o  o  
I know how 
important the 
risks and side 
effects are to 
me in this 
decision (8)  
o  o  o  o  o  
It’s hard to 
decide if the 
benefits are 
more important 
to me than the 
risks, or if the 
risks are more 
important than 
the benefit (9)  
o  o  o  o  o  
I feel pressure 
from others in 
making this 
decision (10)  
o  o  o  o  o  
 
 
Q48 Please select how strongly you agree or disagree with each of the following statements regarding 
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choice (11)  
o  o  o  o  o  




choice (12)  
o  o  o  o  o  
I feel I have 
made an 
informed 
choice (13)  
o  o  o  o  o  
My decision 
shows what is 
important to me 
(14)  
o  o  o  o  o  
I expect to stick 
with my 
decision (15)  
o  o  o  o  o  
I am satisfied 
with my 
decision (16)  
o  o  o  o  o  
 
 
End of Block: Emotional Response, Decisional Conflict 
 
Start of Block: Open Ended 1 
 
Q49 If this were a real situation, who would you share this information with? (select all that apply) 
▢ Physician    
▢ Family    
▢ Friends    




Q50 If you had to explain in a few sentences what you learned from this session to someone you know, 










End of Block: Open Ended 1 
 
Start of Block: Respect, Satisfaction 
 
Q51 Please select how strongly you agree or disagree with the following statement imagining that you were 
the patient:  
 
 
My genetic counselor has a great deal of respect for me. 
o Strongly Agree    
o Agree    
o Neutral    
o Disagree    
























Q52 Please read each statement below carefully and tell us how much you agree with each statement by 
selecting the number that describes how much you agree or disagree if you were the client seeing the 





End of Block: Respect, Satisfaction 
 
Start of Block: Open Ended 2 
 
Q53 In the session, is there anything you wish you would have been able to ask?  
o Yes    






 Agree  
Agree  Neutral  Disagree  
Strongly 
Disagree  
My genetic counselor 
seemed to understand 
the stresses I was 
facing.   
o  o  o  o  o  
My genetic counselor 
helped me to identify 
what I needed to know 
to make decisions about 
what should happen to 
me.   
o  o  o  o  o  
I felt better about my 
health after meeting 
with my genetic 
counselor.   
o  o  o  o  o  
The genetic counseling 
session was about the 
right length of time I 
needed.   
o  o  o  o  o  
My genetic counselor 
was truly concerned 
about my well-being.   
o  o  o  o  o  
The genetic counseling 
session was valuable to 
me.   
o  o  o  o  o  
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Q55 In the session, is there anything you wish you would have been able to say? 
o Yes    











End of Block: Open Ended 2 
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Q57 Please answer True or False to the following questions: 
 True  False  
Early-onset breast cancer is 
less likely due to an altered 
BRCA gene than is late-
onset breast cancer.   
o  o  
A woman who has a sister 
with an altered BRCA gene 
has a 50% risk of having an 
altered gene herself.   
o  o  
A woman who has her 
breasts removed can still 
get breast cancer.   
o  o  
A father can pass down an 
altered BRCA gene to his 
children.   
o  o  
One in 10 women have an 
altered BRCA gene.   o  o  
There are many different 
genes that cause cancer.   o  o  
One half of breast cancer 
cases occur in women who 
have an altered BRCA 
gene.   
o  o  
Tests for ovarian cancer 
often do not detect a tumor 
until it has spread. (8)  
o  o  
All women who have an 
altered BRCA gene will get 
cancer. (9)  
o  o  
A woman who does not 
have an altered BRCA gene 
can still get breast or 
ovarian cancer. (10)  
o  o  
Having ovaries removed 
will definitely prevent 
ovarian cancer. (11)  
o  o  
 
 
End of Block: Knowledge 
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End of Block: Open ended 3 
 
Start of Block: Verisimilitude 
 




Q66 How easy was it for you to take on the patient role when viewing the video genetic counselor? 
o Very difficult    
o Hard    
o Easy    
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Q67 How real did the genetic counselor in the video seem? 
o Not at all real    
o Somewhat real    
o Real    




Q68 How similar was the genetic counselor to health care you have received in the past? 
o Not at all similar    
o Somewhat similar    
o Similar    
o Very similar    
 
End of Block: Verisimilitude 
 
Start of Block: Answering questions, integrity 
 
Q69 When the genetic counselor asked you a question, how often did you answer the question (out loud or 
in your head)? 
o Not at all    
o Some of the time    
o About half of the time    
o Most of the time    




Q70 The integrity of our research data is important to us. Have you answered the survey questions 
honestly? You will be compensated regardless of your answer, and your answer will not be linked to your 
email address or personal information. 
o Yes    
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End of Block: Answering questions, integrity 
 
Start of Block: Thank you 
 
Q71 Thank you for participating in our study. We would like you to keep in mind that this study is 
hypothetical and in no way reflects your personal risk for cancer.  If you would like to meet with a genetic 
counselor, please visit NSGC.org and click on “Find a Genetic Counselor” to locate one in your area. If 
you would like to contact the researchers about questions or concerns, please refer to the contact 
information provided below.    
 
Researchers’ Contact Information:    
 
Emily Bonkowski       
Co-Investigator         
Genetic Counseling Graduate Student     
JHU/NHGRI Genetic Counseling Program     
emily.bonkowski@nih.gov    
    
Lori Erby, PhD, CGC   
Principal Investigator   
JHU/NHGRI Genetic Counseling Training Program   
lori.erby@nih.gov   
 
 On the next page, you will be taken to a new website where you can enter your email address to 
receive compensation for the study. The electronic Amazon gift card code will be emailed to you 
within a few days. Your personal contact information will not be linked to the answers you gave or 
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APPENDIX D: Video Genetic Counseling Scripts 
 
HIGH COMPLEXITY 
Hello, my name is Mary, and I’m a genetic counselor. I’ve taken a look through your 
records and have a good idea of what brings you in today. We’ll be talking about your 
sister’s recent diagnosis of breast cancer and how, from a genetic standpoint, we might 
think about your situation. 
I have a plan for what I think might be helpful for us to talk about in our time together, 
but I was wondering if you could tell me in your own words what brings you in today, 
and if you have any questions before we get started? 
Thanks, it’s helpful to know where you’re coming from, and I hope I’ll be able to answer 
most of those questions. So, today, we’ll review what we know about the genetics of 
cancer, particularly breast cancer and related cancer syndromes. We’ll also talk about 
how they track in certain high-risk families. Then, we can talk more about the genetic 
testing that we have available, and what kinds of results we can get from a genetic test. If 
you decide to have testing, depending on the results of the test, there may be specific 
recommendations that we would make for you and other family members. This would 
include breast and ovarian cancer surveillance, treatment, and potential consideration of 
prophylactic surgeries to reduce the risk of cancer for you if the test comes back positive. 
So, let’s review what we know about the inheritance of breast and ovarian cancer 
syndromes and breast cancer in general.  We’ll also go over some basic genetics 
concepts. 
 When we think about who develops cancer, we know that most cancer is sporadic, and 
we don’t have a known cause of that cancer. Cancer is multifactorial.  That means that it 
can be caused by multiple different factors, including a mixture of environmental, 
lifestyle, and genetic contributors. 
We know that only 5-10% of cancer is hereditary. Of those hereditary cancers, there are a 
small proportion that have a genetic cause that we can identify today. Hereditary cancers 
are more likely to have individuals with younger onset cancer, multiple generations of 
family members affected, and multiple related cancers--such as breast and ovarian--in the 
same family. 
 Okay? 
If we think about genetics, from high school biology you might remember that every part 
of our body is made up of thousands and thousands of cells. And in every cell of our 
body there are structures called chromosomes. Chromosomes package our genetic 
material together. We have 46 chromosomes in every cell of our body. They come in 
pairs, and are numbered by size from one to 22. The first 22 pairs are exactly the same in 
both men and women, and you get one half of each pair from your mother and the other 
half from your father. The last pair is the sex chromosomes. Women are XX and males 
are XY. When you have a child, you pass on one from each set. The child then has 50% 
of his or her chromosomes from the father and 50% from the mother. 
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On each chromosome, there are hundreds to thousands of genes. Normally, everyone has 
two copies of each gene, one copy from each parent. Those genes are made up of DNA. 
The DNA bases code for amino acids, which code for proteins. Proteins have a variety of 
functions within the body. Essentially, the genes we have are the instructions that tell our 
body how to develop, grow, and function. This includes things like determining our eye 
color and how curly our hair is. 
Do you have any questions? 
We know that there are certain genes that function to help prevent cancer. These genes 
come in a few different types, including tumor suppressor genes, oncogenes, and DNA 
repair genes that work to detect errors in the way that cells are proliferating. Several 
genes scientists have discovered confer a higher risk for developing breast cancer when 
something in the spelling of the gene is wrong or mutated. For instance, some studies 
have shown that women who have a variant, in one of these genes might have a lifetime 
risk of up to 80-85% of developing breast cancer, and up to 40% risk of developing 
ovarian cancer. In the general population, the lifetime risk for breast cancer is 12% in 
women. The lifetime risk for ovarian cancer is about 1-2% in women. 
From researching many families with more cancer than average, we have discovered a 
few genes that predispose individuals to developing cancer in their lifetimes. The first 
two breast cancer genes, BRCA1 and BRCA2, were first discovered in the 1990s by 
studying families with a lot of women who were getting cancer at young ages. 
Have you heard of BRCA1 and BRCA2 before today? 
Okay. Since that time, many women with early onset breast and ovarian cancers have 
been genetically tested. We now have a better idea of which gene variants confer a 
predisposition to cancer. 
Often, people with variants in these genes will develop cancer at an earlier age, under the 
age of 50, or the cancer will have a specific pathology. For example women with cancer 
due to a BRCA1 variant are more likely to have triple negative breast cancer compared to 
the women who have sporadic cancer that isn’t due to a BRCA1 variant. 
Now, the variants that I’m talking about can happen in two ways.  The first way is that a 
variant can come through the germline. This means you inherited it from one of your 
parents and that it was present in the sperm cell or the egg cell at conception. In this case, 
the variant is present in all of the cells in the body. The second way a variant can occur in 
the body is that it can be acquired in a single cell at some point in a person’s life. 
 Okay? 
In order for cancer to develop, two variants actually need to be present.  First in one copy 
of that gene, then in the other copy of that gene, so that there are no working copies. They 
call this the two hit hypothesis. We now know it’s more than a hypothesis. When these 
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When there’s one copy of a gene that has a variant, that makes someone a carrier. Being a 
carrier, or having a germline variant means that that person has a predisposition to cancer. 
It’s not a guarantee that the person will develop cancer. There is still one functioning 
copy, but a second hit or a second variant in the other copy of the gene can happen. Then 
there are no working copies of the gene. When that happens cancer is more likely to 
occur.             
Do you have any questions about any of that? 
After our visit, I will send you a letter that has the main points of what we talked about 
today, so hopefully that will also help to answer your questions. 
I’d now like to go over what testing we could offer you. When we test individuals for 
genetic changes that predispose someone to cancer, it’s usually best to test a person who 
has been affected with cancer first. That way, if the test is positive, we know what is 
causing the cancer in that person and what test should be offered to the rest of the family.  
If it’s negative, we know that there isn’t an identifiable genetic cause for the cancer at 
this time. We would know that we wouldn’t be able to test additional family members. If 
the affected person tests negative, that wouldn’t necessarily mean that there isn’t 
something genetic or inherited that is causing the cancer. It could mean that we haven’t 
discovered the gene yet. Or, it could mean that the cancer was caused by something else. 
A negative test can be difficult to interpret. 
If we were to test you today without testing someone in the family who has had cancer, if 
it were positive, we would say that you are at a higher risk to develop cancer. If we tested 
you today and you were negative, you would be an uninformative negative. That would 
mean that we wouldn’t be able to tell if you were truly negative and didn’t inherit what 
genetic variant is causing the cancer in your sister, or if you are negative because if we 
tested your sister, we wouldn’t have found anything, so we wouldn’t have found anything 
in you anyway. I see that your sister isn’t interested in getting tested, and maybe that’s 
something that you could talk to her about later, after her cancer treatment is over. We are 
still able to test you, even though it might be harder to interpret your results and what 
they would mean for your genetic risk for cancer. Having a first degree relative affected 
with breast cancer (your sister) increases your risk for developing cancer yourself 
regardless of genetic testing. We’d like you to be diligent about your mammograms and 
regular cancer screenings no matter what genetic testing might tell us. 
Does that make sense? 
The test we would offer you today is a cancer panel test which looks for variants or 
changes in ten genes we know are associated with the development of breast cancers. 
Variants in these genes can also indicate that you are at an increased risk for other types 
of cancers, including ovarian, pancreatic, thyroid, prostate cancer in men, and melanoma, 
among others. The test uses sequencing technology and quantitative methods to look for 
changes in the gene, such as spelling errors or extra or missing pieces, such as insertions, 
duplications, or deletions. These ten genes have been grouped together onto one test, 
because for each of these ten genes, there are professional guidelines for how to change 
medical management based on finding a variant. There may be screening protocols or 
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surgical options to consider. 
The first two genes on the panel we know more about, BRCA1 and BRCA2, which I 
mentioned earlier, and variants in both of these genes predispose you to develop breast 
and ovarian cancers. The risk for breast cancer for people with pathogenic variants in 
BRCA1 or BRCA2 is as high as 80-85% by age 70. The ovarian cancer risk in BRCA1 is 
39% by age 70, and for BRCA2 it’s 11-17% by age 70. As we talked about earlier, these 
risks are substantially higher than for women who do not have variants in BRCA1 or 
BRCA2. For women without variants in BRCA1 or 2, the lifetime risk for breast cancer 
is about 12% and the lifetime risk for ovarian cancer is about 1-2% in women. 
The other genes we are looking at are genes that have been reported in the literature as 
being associated with breast cancer, but may have a lower penetrance. This means that 
the risk for cancer would not be as high. As I mentioned, a few of them are associated 
with other types of cancer--ovarian, pancreatic, thyroid, prostate, melanoma--and there 
would be specific recommendations we would make for you based on what the genetic 
test tells us. There might be some screening or imaging tests we would recommend to 
detect any development of cancer in those areas. Unfortunately, for some kinds of cancer, 
including ovarian cancer and pancreatic cancer, there are no medically sensitive tests that 
can reliably detect early stage cancers. 
The genetic test that we can offer won’t be able to tell you when you will get cancer, or 
even if you will get cancer.  None of the genes come with a 100% certainty that someone 
will get cancer if they have a variant in that gene. The uncertainty about whether or not 
you get cancer could potentially cause some worry and anxiety. It’s important to think 
about what this test would mean for you. 
So, from doing this genetic test, there can be three outcomes: a positive test result, a 
negative test result, or an uncertain test result. 
The first outcome could be that the test is positive. This would mean that we have found a 
pathogenic variant in your DNA that predisposes you to developing breast cancer, and 
potentially other cancers in your lifetime. 
If the test is positive, there would be specific medical recommendations and medical 
decisions for you to think about. 
In that case, the first important thing to think about would be breast cancer screening and 
surveillance. With a positive test, the professional guidelines recommend breast 
mammography and breast MRI done every six months, alternating, for early detection if 
breast cancer develops. The MRI is an additional method of imaging the breast tissue.  It 
can be useful in detecting cancer in younger women as well as in women who have dense 
breast tissue. 
Another thing to think about is that if you do develop breast cancer at some point in your 
life, having a positive genetic test result would increase your risk for having an additional 
primary cancer in a brand new spot in your breast or in the other breast. Some women 
choose to have a prophylactic mastectomy to remove both breasts as a preventative 
measure. Removing the breast tissue greatly reduces the risk for breast cancer, but 
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doesn’t reduce it all the way to zero. There may be a few breast tissue cells left over after 
surgery. Clinical breast exams of the chest wall would be a good way to continue to do 
breast screening after a double mastectomy. In women who choose this, many also 
choose to do reconstructive surgery at the same time. Some women choose to have a 
preventative mastectomy so that they do not have to do the intensive screening of 
mammography and MRI every 6 months. 
In the case of breast cancer, a lumpectomy could also be an option, to just remove the 
cancerous cells. You would then continue doing screening to detect any recurrence or 
new primary cancer in the remaining breast tissue. 
While the risk for breast cancer is one of our priorities, variants in some of these genes, 
like BRCA1 and BRCA2 can increase a woman’s risk for ovarian cancer. So, the second 
thing to think about, in the case that the genetic test is positive for a variant in a gene that 
also increases risk for ovarian cancer would be to consider the surgical removal of the 
ovaries and the fallopian tubes. Unlike breast tissue, the ovaries and fallopian tubes 
(which can also develop cancer) are harder to access. The current screening methods we 
have, including PAP smears, testing hormone levels like CA125, and ultrasounds aren’t 
particularly sensitive. If those tests pick up cancer it is often at a later stage. Because of 
this, we would recommend the removal of your ovaries after you are done having 
children, by your late thirties or early 40s. Removing the ovaries not only greatly reduces 
the risk for ovarian cancer by about 96%, but it also reduces the risk for breast cancer by 
about 50%. However, removing the ovaries forces the body to go into premature 
menopause. This may not be ideal or comfortable, and you can talk to your doctor about 
how you might manage the symptoms of menopause. 
Also, if you were to test positive, we could begin offering genetic testing to your other 
family members who are at risk. Because these variants are usually passed on from 
generation to generation, and inherited from a mother or father, we know that your first 
degree relatives would have a 50% risk, like the flip of a coin, of having the same variant. 
Both men and women can pass on these variants. This would include your siblings, 
parents, and children. Extended family members could also be at risk. 
The test result would have implications for men in your family as well. While breast 
cancer is more common in females, it can also happen in males, and males who carry a 
BRCA variant are at a higher risk of developing male breast cancer as well as at an 
increased risk for developing prostate cancer.   
 You may have questions about testing children in the family. We don’t recommend 
testing children under the age of 18, as there are no known associations with childhood 
cancer in most of the genes we are testing. We recommend waiting until at least 18 so 
that they are able to make that decision for themselves. Even at 18, individuals might not 
want to or feel ready to do genetic testing. 
 Overall, you should know that if the test comes back positive, we would make a plan for 
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The second possible result could be a negative result. For you, this would mean that we 
did not find any variants in the genes we looked at that we know are most highly 
associated with an increased risk of developing breast and related cancers. As we talked 
about earlier, this does not necessarily rule out the possibility that there is an inherited 
cancer running in your family.  You would still be at increased risk above the general 
population given your family history of breast cancer at an early age in your sister. 
However, we can have some reassurance that we did not find any variants in the genes 
we looked at, including the highest risk BRCA1 and BRCA2 genes. 
If you get a negative result, we would still want you to be vigilant about getting screened 
for breast cancer because of your family history. You should talk to your doctor about 
coming in earlier than you might usually be recommended to, to get mammograms. This 
would be the case even if you decide not to get testing at all. If your sister were ever to 
get tested, and she did end up testing positive, we would then know that you did not 
inherit the same variant that she has from one of your parents. This would mean you and 
your children would not be at a higher risk to develop cancer than the general population. 
Without her results, as I mentioned earlier, we would still be left not knowing whether or 
not our testing would have detected the cause of cancer in your family. 
The third type of test result is a variant of uncertain significance. This would mean that 
we found something in one or more of the genes that we tested you for, but that we aren’t 
sure if it is benign and doesn’t increase risk for cancer or pathogenic and does increase 
risk for cancer. Over time, laboratories continue to do research, and continue to test 
people with and without cancer to determine which genetic variants are associated with 
cancer and which ones are just common variation in the population. We all have genetic 
differences and variation, so this is a case where knowing more about normal human 
variation can help us learn more. As the lab collects more information, it is possible that 
they will reclassify the variant as either benign or pathogenic. They will contact us if and 
when that happens, and we will pass the information on to you so that you can 
incorporate that information into your own medical management. If your test result has 
an uncertain variant, we would not recommend that you change your medical care, but 
that you should continue to get regular cancer screenings. 
That was a lot of information, do you have any questions about what I just went over 
about the three kinds of results? 
 One last thing we like to tell our patients about is something called the Genetic 
Information Nondiscrimination Act or GINA. Whenever someone has genetic testing 
done, that genetic information and the test result are placed in the medical record. There 
is a law that protects individuals from being discriminated against based on their genetic 
information. This protects discrimination in employment and health insurance. The areas 
that GINA does not cover are long-term care, life insurance, and disability coverage. 
Currently, insurance agencies are allowed to ask for your information, and could make a 
policy decision based on that. For this reason, some people like to have their plans in 
place before proceeding with genetic testing. Current policies would not be affected, but 
if you were to apply in the future, those types of insurers would be allowed to ask for 
genetic information. In my experience, this hasn’t been a major issue or problem for 
anyone, but it is something to consider. 
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Okay? 
 So, after our discussion today, if you think this testing is something you’d like to do, we 
could do the test today. You can also go home to think about it or decide not to do testing 
at all at this point, knowing that you can always revisit the issue later. Logistically, it 
would be a simple blood draw, and we would send the sample to the lab, and give you a 
call with the results over the phone. If the results are positive, we would want to have you 
come back in and talk to you about what the specific recommendations are, given what 
we find and which gene has a variant. If your test is negative or uncertain, we’re also 
happy to meet with you again or speak over the phone to answer any questions you have 
about what the test means for you and your family. 
We’ve gone over some genetics, and the genetic causes of cancers, including risks and 
testing options, as well as the test results, and what we would do with those results. 
Testing is a personal choice and is optional. Many people have conversations with family 
and other people before deciding whether or not to pursue testing. Hopefully it’s been 
helpful to hear some of the information today. 
Do you have any additional questions? 
Given what we’ve talked about, would you want to do the genetic test? [Yes/No] 
________________________________________________________________________ 
MEDIUM COMPLEXITY 
Hello, my name is Mary, and I’m a genetic counselor. I’ve looked through your records 
and have a good idea of what brings you in today. We’ll be talking about your sister’s 
recent diagnosis of breast cancer and how we might think about your situation from a 
genetic standpoint. I have a plan for what might be helpful for us to talk about today. 
I wonder if you could tell me in your own words what brings you in today? 
Do you have any questions before we get started? 
Thanks, it’s helpful to know where you’re coming from. I hope I can answer most of 
those questions. So, today we’ll review what we know about the genetic causes of cancer, 
and how cancer can be passed on in certain families. We will go over breast cancer as 
well as other cancers--like ovarian cancer--that can come from the same genetic cause. 
Then, we can talk more about the genetic testing that we have available, and what kinds 
of results we can get from a genetic test. If you decide to have testing, your doctor may 
want you to change your medical care to help reduce your chance of getting cancer. This 
will depend on what the results show us.  Because of the way cancer can be passed in 
families, your results may also affect other close family members, and they may also 
want to get tested. 
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So, let’s review what we know about what causes breast cancer and how it might be 
passed down in families. We’ll also go over some basic genetics concepts. 
When we think about who gets cancer, we usually don’t know what caused the cancer. 
Cancer is multifactorial. That means that it can happen because of many causes like the 
environment, a person’s lifestyle, as well as a person’s genetics. 
We know that only a small amount--5-10%--of cancer is thought to be hereditary, or 
running in families. In cancers that are running in families, only a small number have a 
genetic cause we can identify. Hereditary cancers are more likely to have individuals with 
younger onset cancer, multiple generations of family members affected, and multiple 
related cancers--such as breast and ovarian--in the same family. 
In your case, we know that your sister was diagnosed at a younger age, in her 40s, which 
makes us wonder if she has a genetic change that caused her to get cancer. 
Okay? 
Our body is made up of thousands and thousands of cells. Every cell in our body contains 
our all of our genetic information. Our genetic information contains something called 
genes. Genes are the instructions that tell our body how to grow and develop, like giving 
us eye color or how curly our hair is. Genes help control the functions in our body. We 
each have two copies of every gene, one that we get from our mom, and one that we get 
from our dad. 
Do you have any questions about that? 
We know that there are certain genes that function to help prevent cancer. A few genes 
scientists have discovered, such as BRCA1 and BRCA2, are associated with a higher risk 
of getting breast cancer when something in one of those genes is changed so that the gene 
doesn’t work properly. For instance, women who have a variant in one of these genes has 
a higher chance of getting breast and ovarian cancer compared to women who do not 
have a variant. 
From researching many families with more cancer than average, we have discovered a 
few genes that can cause individuals to get cancer. 
Have you heard of BRCA1 and BRCA2 before today? What have you heard or learned 
about? 
Okay. Over the last 30 years, many women with early onset breast and ovarian cancers 
have had genetic testing. We now have a better idea of which gene variants can cause 
cancer. 
Often, people with variants in these genes will get cancer at an earlier age, under the age 
of 50. The cancer can look a certain way. For example women with cancer due to  
BRCA1 variant are more likely to have triple negative breast cancer than women who 
don’t have a BRCA1 variant. 
Now, the variants that I’m talking about can happen in two ways.  The first way is that 
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you can be born with a variant that came from your mom or your dad. In that case, that 
variant is present in all of the cells in your body. The second way a variant can occur in 
the body is that it can be acquired in a single cell at some point in a person’s life. 
 Okay? 
In order for cancer to develop, two variants actually need to be present.  First in one copy 
of that gene, then in the other copy of that gene in the same cell, so that there are no 
working copies. When these genes don’t work, cells can grow out of control, which turn 
into cancer and tumors in the tissue. 
 When there’s one copy of a gene that has a variant, that makes someone a carrier. Being 
a carrier means that person has a predisposition to cancer. It’s not a guarantee, because 
there is still one functioning copy. A second hit or a second variant in the other copy of 
the gene can happen. Then there are no working copies of the gene, and cancer is more 
likely to occur. 
 That was a lot of information about cancer and genetics--what questions do you have 
about that? 
I’m not sure if I explained it all clearly--could you try to summarize what I said so that I 
can be sure that I got across the important information? 
That seems about right. After our visit, I will send you a letter that has the main points of 
what we talked about today. Hopefully that will also help to answer your questions. 
I’d now like to go over what testing we could offer you. It’s usually best to test the 
affected person in a family first. That way, if the test is positive, we know what is causing 
the cancer in that person. We also know what test should be offered to the rest of the 
family. If it’s negative, we know that there isn’t a known genetic cause for the cancer at 
this time. We would know that we wouldn’t be able to test other family members. 
I see that your sister isn’t interested in getting tested, and maybe that’s something that 
you could talk to her about later, after her cancer treatment is over. We are still able to 
test you, even though it might be harder to interpret your results and what that means for 
your genetic risk for cancer. Either way, having a first degree relative increases your risk 
for developing cancer yourself. We’d like you to be on top of your mammograms and 
cancer screenings either way. 
Does that make sense? What questions do you have about that? 
The test we would offer you today is a cancer panel test which looks for variants or 
changes in ten genes we know we know can cause someone to get breast cancer. Variants 
in these genes can also indicate that you have a chance of getting other types of cancers. 
That includes ovarian, pancreatic, thyroid, melanoma, among others. The test looks for 
changes in the gene that causes it not to work properly, including changes to the spelling 
of the gene, or extra or missing pieces. These ten genes have been grouped together onto 
one test because there are specific professional guidelines for how to change medical care 
based on finding a variant in these ten genes. There may be cancer screening or surgical 
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options to consider. 
The first two genes on the panel we know more about, BRCA1 and BRCA2, which I 
mentioned earlier. Variants in both of these genes predispose you to get breast and 
ovarian cancers. The risk for breast cancer in for people variants in BRCA1 or BRCA2 is 
up to 80-85% by age 70. The risk for getting ovarian cancer in BRCA1 is up to 39% by 
age 70, and BRCA2 is up to 17% by age 70. As we talked about earlier, these risks are 
much higher than for women who do not have variants in BRCA1 or BRCA2. 
The other genes we are looking at are genes that have been reported in the literature as 
being associated with breast cancer, but may have a lower penetrance. A lower 
penetrance means that the risk for cancer would not be as high. As I mentioned, a few of 
them are associated with other types of cancer--ovarian, pancreatic, thyroid, melanoma--
and there would be specific recommendations we would make for you based on what the 
genetic test tells us. Unfortunately, for some kinds of cancer, including ovarian cancer 
pancreatic cancer, there are no medically sensitive tests that can reliably detect early 
stage cancers. 
The genetic test that we can offer won’t be able to tell you when you will get cancer, or 
even if you will get cancer. None of the genes come with a 100% certainty that someone 
will get cancer if they have a variant in that gene. The uncertainty about whether or not 
you get cancer could potentially cause some worry and anxiety. It’s important to think 
about what this test would mean for you. 
 Next, I’ll go over the kinds of results you can get from this test, and what the results 
could mean for you and your family. But first, do you have any questions about what is 
included in the panel test? 
So, from doing this genetic test, there can be three outcomes: positive, negative or 
uncertain. 
The first outcome could be that the test is positive, and we have found a pathogenic 
variant in your DNA that predisposes you to developing breast cancer, and potentially 
other cancers in your lifetime. 
If the test is positive, there would be specific medical recommendations and medical 
decisions for you to think about. 
 In that case, the first important thing to think about would be breast cancer screening. 
With a positive test, the recommendation is that you have breast mammograms and breast 
MRI. These would be done every six months, alternating. This helps detect breast cancer 
early. The MRI is another method of looking at the breast tissue. It can be useful in 
finding cancer in younger women as well as in women who have dense breast tissue. 
Also, for someone like your sister who has already had breast cancer, a positive genetic 
test result would increase the chance for getting cancer in a brand-new spot in the same 
breast or in the other breast.  Some women choose to remove both breasts with surgery to 
help prevent getting cancer. This way, that they don’t have to do mammography and MRI 
every 6 months. Removing the breast tissue greatly reduces the chance of getting breast 
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cancer. It doesn’t reduce it all the way to zero, though. There may be a few breast cells 
left over after surgery. Breast exams from your doctor would be a good way to continue 
look for breast cancer after removing both breasts. In women who choose to remove their 
breasts, many also choose to have breast reconstruction in same surgery. 
If you were ever to get breast cancer, you could choose to have surgery to remove just the 
cancer cells, without removing the breast. After that you could continue doing screening 
to look for the cancer coming back, or for a new cancer in either breast. 
Variants in some of these genes can also increase a woman’s chance for ovarian cancer. 
If the test is positive and you have a variant in one of those genes, you would want to 
consider having surgery to remove your ovaries as well as your fallopian tubes. Unlike 
breast tissue, the ovaries and fallopian tubes (which can develop cancer) are harder to 
access. The current screening methods we have aren’t very effective. If they pick up 
cancer it is often at a later stage. Because of this, we would recommend the removal of 
your ovaries after you are done having children, but by your late thirties or early 40s. 
Removing the ovaries not only greatly lowers the risk for ovarian cancer by 96%, but it 
also reduces the risk for breast cancer by 50%. However, removing the ovaries forces the 
body to go into premature menopause. That may not be ideal or comfortable. You can 
talk to your doctor about how you might manage those symptoms. 
What questions do you have so far? 
Okay. Also, if you were to test positive, we could begin offering genetic testing to your 
other family members who are at risk. We know that your close relatives, your parents, 
siblings, and children would have a 50%, like the flip of a coin, chance of having the 
same variant. Gene variants are usually passed on from generation to generation, and 
inherited from a parent. Both men and women can pass on the gene variants. Extended 
family members could also be at risk. 
While breast cancer is more common in women, it can also happen in men. Men who 
carry a BRCA variant are at a higher risk of developing male breast cancer. They are also 
at an increased risk for developing prostate cancer. 
You may have questions about testing children in the family. We don’t recommend 
testing children under the age of 18. here are no increased risks for cancers in childhood 
in most of the genes we are testing. We recommend waiting until at least 18. At that age, 
they can make that decision for themselves. Even at 18, some people might not want to 
do genetic testing. 
Overall, you should know that if the test comes back positive, we would make a plan for 
how to move forward for you and your family, to help prevent and detect cancer in the 
future. 
We’ve gone over what we would do and think about if you had a positive results--can you 
tell me how you’re thinking about all of this information and what you might do? 
The second possible result could be a negative result. For you, this would mean that we 
did not find any variants in the genes we tested. As we talked about earlier, this does not 
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rule out the possibility that there is hereditary cancer running in your family.  You would 
still be at increased risk above the general population given your family history of breast 
cancer at an early age in your sister. However, we can have some reassurance that we did 
not find any variants in the genes we tested. 
If you get a negative result, there would be no specific change in your medical care. You 
would still need to be serious about getting screened for breast cancer. You should talk to 
your doctor about when to get mammograms. This would be the case even if you decide 
not to get testing at all. 
It would be helpful to know if your sister had testing later and got a positive result. 
Because your test result was already negative, we would know that you did not inherit the 
same variant that she has from one of your parents. That would mean that you and your 
children would not have a higher chance of getting cancer. Your children cannot inherit 
something from you that you do not have. 
What would the plan be if you got a negative result? 
The third type of test result is a variant of uncertain significance. This means that we 
found something in one or more of the genes that we tested you for. But that we wouldn’t 
be sure whether or not it increases your chance of getting cancer. Over time, scientists 
continue to do research. They continue to test people with and without cancer to 
determine which genetic variants are associated with cancer. As the lab collects more 
information, it is possible that they reclassify or relabel the variant as either positive or 
negative. They will contact us if and when that happens.  We would pass the information 
on to you and your doctor. If your result has an uncertain variant, we would not 
recommend that you change your medical care, but that you should continue to get 
regular cancer screenings. 
 What would the plan be if you got an uncertain result? 
That was a lot of information, do you have any questions about what I just went over 
about the three kinds of results? 
 I also want to talk to you about something called the Genetic Information 
Nondiscrimination Act or GINA. Genetic testing results are placed in the medical record. 
There is a law that protects people from being discriminated against based on their 
genetic information. This means that your employer and your health insurance company 
can’t treat you differently based on your genetic test results. This law does not apply to 
long-term care, life insurance, and disability insurance.  As of now, those kinds of 
insurance agencies can ask about genetic testing.  They are also allowed to refuse to give 
you insurance based on that.  They are also allowed to charge you more for insurance 
based on your genetic test results.  For this reason, some people like to have their plans in 
place before having genetic testing. If you already have insurance, that would not be 
affected.  I have not heard of anyone having a problem with this, but it is something to 
consider. 
Any questions about that? 
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Okay. If you think this testing is something you’d like to do, we could do the test today. 
You can also go home to think about it or decide not to do testing at all at this point, 
knowing that you can always revisit the issue later. Logistically, it would be a simple 
blood draw, and we would send the sample to the lab, and give you a call with the results 
over the phone. If the results are positive, we would want to have you come back in and 
talk to you about what the specific recommendations are, given what we find and which 
gene has a variant. If your test is negative or uncertain, we’re also happy to meet with 
you again or speak over the phone to answer any questions you have about what the test 
means for you and your family. 
We’ve gone over some genetics, and the genetic causes of cancers, including risks and 
testing options, as well as the test results, and what we would do with those results. 
Testing is a personal choice and is optional. Many people have conversations with family 
and other people before deciding whether or not to pursue testing. Hopefully it’s been 
helpful to hear some of the information today. 
What other questions do you have? 
Given what we’ve talked about, would you want to do the genetic test? [Yes/No] 
________________________________________________________________________ 
LOW COMPLEXITY 
Hello, my name is Mary, and I’m a genetic counselor. I’ve looked through your records 
and have a good idea of what brings you in today. We’ll be talking about your sister’s 
recent diagnosis of breast cancer and how we might think about your situation from a 
genetic standpoint. 
 I have a plan for what might be helpful for us to talk about today. I wonder if you could 
tell me in your own words what brings you in today? 
 What questions do you have s before we get started? 
 Thanks, it’s helpful to know where you’re coming from. I hope I can answer most of 
those questions. So, today we’ll review what we know about the genetic causes of cancer, 
and how cancer can be passed on in certain families. We will go over breast cancer as 
well as other cancers--like ovarian cancer--that can come from the same genetic cause. 
Then, we can talk more about the genetic testing that we have available, and what kinds 
of results we can get from a genetic test. If you decide to have testing, your doctor may 
want you to change your medical care to help reduce your chance of getting cancer. This 
will depend on what the results show us.  Because of the way cancer can be passed in 
families, your results may also affect other close family members, and they may also 
want to get tested. 
We’ve gone over what we would do and think about if you had a positive results--can you 
tell me how you’re thinking about all of this information and what you might do? 
When you think about what causes cancer, what comes to mind? 
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 That’s a good answer. Why don’t I review what we know about what can cause breast 
cancer and how it can be passed down in families. 
 When we think about who gets cancer, we usually don’t know what caused the cancer. It 
could be the environment, a person’s lifestyle, their genes, or all those things together. 
We know that most cancers are not hereditary and do not run in families.  For those 
families that do have hereditary cancers, only a small percent are caused by changes in 
genes. 
 Do you have any questions about that? 
 Genes are the instructions that tell our body how to grow and develop, like what color 
our eyes are or how curly our hair is. Genes have specific functions in our body. We get 
our genes from our parents. 
 We know that there are certain genes that work to help prevent cancer. When these genes 
don’t work, cells can grow out of control, which turn into cancer and tumors in the body. 
Women who have a change or variant in one of these genes that keep the genes from 
working have a higher chance of getting breast and ovarian cancer compared to women 
who do not have that kind of variant. Often, people with variants in these genes will get 
cancer at an earlier age, under the age of 50. The cancer may also have certain features. 
 I’m not sure if I explained it all clearly--could you try to summarize what I said so that I 
can be sure that I gave you the important information? 
 How does this information help you think about your sister’s cancer? 
 That seems about right. After our visit, I’ll send you a letter that has the main points of 
what we talked about today. Hopefully that will also help to answer your questions. 
 Let’s go over what testing we could offer you. It’s usually best to test a person who has 
been affected with cancer first.  I see that your sister isn’t interested in getting tested. 
Maybe that’s something that you could talk to her about later, after her cancer treatment 
is over. You should know that it might be harder to know what your results would mean 
for your risk for cancer if we don’t have your sister’s results first. However, we are still 
able to test you. There is a chance that you would get results that would be helpful to you. 
 Having a close relative with breast cancer (your sister) increases your risk for getting 
breast cancer yourself.  We’d like you to be on top of your mammograms and cancer 
screenings no matter what genetic testing might tell us. 
Does that make sense? 
 The test we would offer you today is a cancer panel test. The panel test looks for variants 
in ten genes we know can cause someone to get breast cancer. Variants in these genes can 
also show that you have a chance of getting other types of cancers. For some of the 
genes, like BRCA1 and BRCA2, we have a good idea of how high the risk of cancer 
could be.  For others, we’re still learning and will not have as much information to share. 
All the genes we are testing are known to cause breast cancer in some people. Depending 
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on the result, your doctor might want to change how you’re screened for cancer. There 
may also be surgeries to consider to help prevent you from getting cancer. 
 The genetic test that we can offer won’t be able to tell you when you will get cancer, or 
even if you will get cancer. None of the genes come with a 100% certainty that someone 
will get cancer, even if they have a variant in that gene. The uncertainty about whether 
you will get cancer could potentially cause you some worry and anxiety. It’s important to 
think about what this test would mean for you. 
 Next, I’ll go over the kinds of results you can get from this test, and what the results 
could mean for you and your family. But first, what questions do you have about what is 
included in the panel test? 
 So, this genetic test can have three kinds of results: positive results, negative results, or 
uncertain results. 
 First, let’s talk about a positive result. A positive result means the test found a variant in 
one of the genes that could cause you to get breast cancer--and maybe other cancers--at 
some point in your life. 
 If the test is positive, there are specific medical care changes and medical decisions for 
you to think about. 
 In that case the first important thing to think about would be breast cancer screening. 
With a positive test, the recommendation is that you have breast mammograms and breast 
MRI.  These would be done every six months, alternating. This helps ensure that if you 
get breast cancer, it is detected early. The MRI is another way of looking at the breast 
tissue. It can be useful in finding cancer in younger women and women who have dense 
breast tissue. 
 Also, for someone like your sister who has already had breast cancer, a positive genetic 
test result would increase the chance for getting cancer in a brand-new spot in the same 
breast or in the other breast. Some women choose to remove both breasts with surgery to 
help prevent getting cancer. Removing both breasts greatly decreases the chance of 
getting breast cancer. It doesn’t decrease it all the way to zero, though.  
 If you were ever to get breast cancer, you could choose to have surgery to remove just 
the cancer cells, without removing the breast. After that you could continue doing 
screening to look for the cancer coming back, or for a new cancer in either breast. 
 These would be choices that you could talk about further if your genetic testing shows a 
positive result. 
Variants in some of these genes can also increase a woman’s chance for ovarian cancer. 
If you have a variant in one of those genes, you would want to consider having surgery to 
remove your ovaries as well as your fallopian tubes. The way we can screen for ovarian 
cancer isn’t very effective. So, it’s hard to find ovarian cancer at an early stage. Doctors 
recommend taking out your ovaries and fallopian tubes after you are done having 
children to lower the chance of getting cancer. This decreases your chance of getting 
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ovarian cancer and lowers the chance of getting breast cancer. 
There are downsides to consider, though.  Removing your ovaries forces your body to go 
into menopause earlier than you would have. That may not be ideal or comfortable. 
You’ll be able to talk to your doctor about how you might manage those symptoms. 
What questions do you have so far? 
Okay. If you tested positive, we could begin offering genetic testing to your other family 
members who are at risk. Gene variants are usually passed on through families, from 
mothers or fathers to their children. Both men and women can pass on the gene variants. 
Your close relatives--your parents, brothers and sisters, and children--would have a 50/50 
chance of having the same variant. It’s like the flip of a coin. Other, more distant relatives 
could also be at risk. 
 While breast cancer is more common in women, it can also happen in men. Men who 
carry a BRCA variant are at a higher risk of getting breast cancer.  They are also at 
increased risk for getting prostate cancer. 
 You may have questions about testing children in the family. We don’t recommend 
testing children under the age of 18. There are no increased risks for cancers in childhood 
in most of the genes we are testing. We recommend waiting until at least 18. At that age, 
they can make that decision for themselves. Even at 18, some people might not want to 
do genetic testing. 
 Overall, you should know that if the test comes back positive, we would make a plan for 
how to move forward for you and your family, to help prevent and detect cancer in the 
future. 
 We’ve gone over what we would do and think about if you had a positive results--can 
you tell me what the plan would be for you if you got a positive result? 
 What about for your family? 
 If you get a negative result, there would be no change in your medical care. But you 
would still need to be serious about getting screened for breast cancer because of your 
family history. You should talk to your doctor about when to get mammograms. This 
would be the case even if you decide not to get testing at all. 
It would be helpful to know if your sister had testing later and got a positive result. 
Because your test result was already negative, we would know that you did not inherit the 
same variant that she has from one of your parents. That would mean that you and your 
children would not have a higher chance of getting cancer. Your children cannot inherit 
something from you that you do not have. 
 What do you think your plan would be if you got a negative result? 
 The third type of test result is a variant of uncertain significance. This would mean that 
we found a change in one of the genes that we tested you for. But, we wouldn’t be sure 
whether or not it increases your chance of getting cancer. Over time, scientists continue 
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to do research. They keep testing people with and without cancer to see which variants 
are related to cancer and which ones are not. As the lab collects more information, it’s 
possible that they will later label the variant as positive or negative. They will contact us 
if and when that happens.  We would then pass the information on to you and your 
doctor. If your result has an uncertain variant, we would not recommend that you change 
your medical care. You should continue to get regular cancer screenings. 
 What do you think your plan would be if you got an uncertain result? 
 I also want to talk to you about something called the Genetic Information 
Nondiscrimination Act or GINA. Genetic testing results are placed in the medical record. 
There is a law that protects people from being discriminated against based on their 
genetic information. This means that your employer and your health insurance company 
can’t treat you differently based on your genetic test results. This law does not apply to 
long-term care, life insurance, and disability insurance.  As of now, those kinds of 
insurance agencies can ask about genetic testing.  They are also allowed to refuse to give 
you insurance based on that.  They are also allowed to charge you more for insurance 
based on your genetic test results.  For this reason, some people like to have their plans in 
place before having genetic testing. If you already have insurance, that would not be 
affected.  I have not heard of anyone having a problem with this, but it is something to 
consider. 
 What questions do you have about that? 
 Okay. We’ve gone over what we know about genetics and cancer. We also talked about 
genetic testing that you could have and what we would do with the results. You should 
know that testing is a personal choice and is optional. Many people choose to talk with 
family and other people before deciding whether to have testing. Hopefully it’s been 
helpful to hear some of the information today. 
What other questions do you have? 
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APPENDIX E: Bivariate Analyses 
 
Table 41. Correlations between Independent Variables 
 
Pairwise Pearson’s correlations were performed to examine correlations between independent variables 
(personal characteristics). Shown are correlation coefficients and p-values.  
 
  Age Non-
Caucasian 
Race 












 1.0000         





-0.2504*   1.0000        
0.0001         
Education 
  
0.0598 -0.2276*  1.0000       
0.3447 0.0001        
Income 
  
0.2072* -0.1720* 0.3346*  1.0000      





0.3854* 0.0301 -0.1329 0.2050*   1.0000     





-0.0853 -0.1534*  0.0569  0.0176 -0.1512*  1.0000    




0.0098 -0.0531 -0.0203  -0.0168  0.0062   0.1053  1.0000    
0.8774 0.3709 0.7327  0.7769 0.9175 0.0759    
GLAC 
  
 0.0786 -0.2330* 0.3357* 0.1127 -0.1185*  0.1145 0.1000  1.0000  
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Table 42. Pearson’s Pairwise Correlations of Personal Characteristics by Outcomes  
First line: Pearson’s Correlation Coefficient 
Second line: p-value 
  Age Non-
Caucasian 
Race 
Education  Household 
Income 











-0.0686 0.1226* -0.1001 -0.1050 -0.0695 0.0874 0.0137  -0.1873* -0.0374 
  0.2797 0.0393 0.0929 0.0778 0.2447 0.1434 0.8185 0.0015 0.5311 
Respect 0.0729 -0.0112 0.0214 0.1094 0.0990 -0.0722 0.0668 0.0864 0.0121 
  0.2486 0.8501 0.7186 0.0647 0.0952 0.2246 0.2601 0.1451 0.8380 
Satisfaction -0.0109 0.0308 0.0216 0.1208* 0.1124 -0.0349 0.0154 0.1338* -0.0917 
  0.8628 0.6041 0.7161 0.0412 0.0580 0.5570 0.7951 0.0237 0.1217 
Knowledge 0.1305*  -0.3630*    0.1843*   0.1900*  0.0255 0.0384 -0.0364 0.3392* 0.2055*  
  0.0384 0.0000 0.0018 0.0012 0.6685 0.5181 0.5403 0.0000 0.0005 
Ease -0.0319 -0.0335 -0.0254 0.0054 -0.0657 -0.0769 0.0369 0.0088 -0.0155 
  0.6155 0.5736 0.6699 0.9282 0.2707 0.1973 0.5355 0.8824 0.7950 
Reality 0.1089 -0.0346 -0.0438  0.1658*   0.1690* -0.0063 0.1003 0.0609 -0.0744 
  0.0858 0.5624 0.4625 0.0052 0.0044 0.9160 0.0921 0.3069 0.2118 
Similarity -0.0401 0.0830 -0.0752 0.0128 0.0512 -0.0515 0.0492 0.0772  -0.1355* 
  0.5296 0.1654 0.2087 0.8303 0.3936 0.3906 0.4110 0.1970 0.0231 
Engagement 0.0030 -0.0484 0.0489 0.0284 -0.0945 -0.0075 0.0899  0.1530* 0.0378 

































































- 181 - 
Table 43. High Complexity Correlations of Personal Characteristics by Outcomes 
 
First line: Pearson’s Correlation Coefficient 
Second line: p-value 
  Age Non-
Caucasian 
Race 
Education  Household 
Income 











-0.0503 0.0939 -0.0608 -0.1185 0.0139 0.0473 -0.0150 -0.0834 -0.0460 
  0.6517 0.3735 0.5650 0.2605 0.8955 0.6543 0.8874 0.4292 0.6636 
Respect -0.0383 -0.0172 0.1190 0.0553 -0.0293 -0.1506 0.1246 0.3117* -0.0150 
  0.7291 0.8702 0.2559 0.5987 0.7804 0.1496 0.2340 0.0024 0.8864 
Satisfaction -0.0863 0.1037 0.1254 0.1738 0.0349 0.0562 0.0692 0.2652* -0.0681 
  0.4351 0.3224 0.2310 0.0956 0.7400 0.5928 0.5099 0.0102 0.5166 
Knowledge 0.1430 -0.3965*  0.2884* 0.1648 0.0028 0.1701 -0.0735 0.4328* 0.0724 
  0.1945 0.0001 0.0051 0.1144 0.9790 0.1031 0.4838 0.0000 0.4901 
Ease -0.0253 0.0064 0.0530 0.0502 -0.0587 -0.1241 -0.0412 0.0863 0.1189 
  0.8191 0.9514 0.6161 0.6347 0.5785 0.2386 0.6963 0.4134 0.2589 
Reality 0.0752 0.1012 -0.0122 0.1468 0.1707 0.0146 0.1266 0.2284* -0.0563 
  0.4993 0.3373 0.9079 0.1627 0.1038 0.8902 0.2292 0.0286 0.5942 
Similarity -0.1376 0.1114 -0.0670 0.0094 0.0762 0.0368 -0.0919 0.0537 -0.1535 
  0.2149 0.2904 0.5257 0.9288 0.4704 0.7278 0.3836 0.6111 0.1440 
Engagement 0.0603 -0.2369*  0.1881 0.0604 -0.2886*  -0.0664 0.0989 0.1877 0.0231 
  0.5856 0.0223 0.0709 0.5651 0.0050 0.5274 0.3454 0.0716 0.8259 
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Table 44. Medium Complexity Correlations of Personal Characteristics by Outcomes 
 
First line: Pearson’s Correlation Coefficient 
Second line: p-value 
 
  Age Non-
Caucasian 
Race 
Education  Household 
Income 











-0.0118 0.0929 -0.3171*  -0.2178*  0.0200 0.1578 0.0962 -0.2897*  -0.0589 
  0.9149 0.3679 0.0016 0.0331 0.8466 0.1247 0.3510 0.0042 0.5687 
Respect 0.1097 -0.1208 0.0759 0.2287* 0.1015 -0.1548 -0.0736 -0.1140 0.1098 
  0.3205 0.2385 0.4602 0.0242 0.3223 0.1300 0.4735 0.2661 0.2843 
Satisfaction -0.0432 -0.0428 0.0468 0.1509 0.1383 -0.1917 -0.0974 0.0100 0.0091 
  0.6962 0.6773 0.6492 0.1401 0.1767 0.0599 0.3427 0.9222 0.9298 
Knowledge 0.1723 -0.2798*  0.1743 0.2184* 0.1139 0.0208 -0.0480 0.3391* 0.4106* 
  0.1170 0.0055 0.0878 0.0316 0.2668 0.8397 0.6406 0.0007 0.0000 
Ease -0.0762 0.0608 -0.1247 -0.0047 -0.1094 -0.0668 0.1637 0.0053 -0.1037 
  0.4937 0.5564 0.2260 0.9636 0.2886 0.5178 0.1109 0.9590 0.3146 
Reality 0.0556 -0.0444 0.0430 0.2179* 0.0511 -0.0840 0.0634 -0.0543 -0.1320 
  0.6152 0.6674 0.6775 0.0329 0.6212 0.4157 0.5395 0.5996 0.2000 
Similarity -0.0169 0.1567 -0.0684 -0.0725 -0.0442 -0.1559 0.0889 0.0682 -0.2647* 
  0.8798 0.1294 0.5101 0.4852 0.6705 0.1314 0.3918 0.5115 0.0095 
Engagement -0.0601 0.1143 -0.1600 0.0310 0.0022 -0.0525 0.1595 0.1033 0.0752 
  0.5892 0.2673 0.1195 0.7644 0.9828 0.6113 0.1205 0.3167 0.4667 
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Table 45. Low Complexity Correlations of Personal Characteristics by Outcomes 
 
First line: Pearson’s Correlation Coefficient 
Second line: p-value 
 
  Age Non-
Caucasian 
Race 
Education  Household 
Income 











-0.1461 0.1869 0.0958 0.0114 -0.2789*  0.1065 -0.0449 -0.1743 0.0132 
  0.1874 0.0697 0.3558 0.9125 0.0065 0.3068 0.6658 0.0912 0.8993 
Respect 0.1316 0.1105 -0.1310 0.0341 0.2236* 0.0651 0.1667 0.1013 -0.0763 
  0.2327 0.2838 0.2033 0.7414 0.0294 0.5305 0.1046 0.3261 0.4601 
Satisfaction 0.1169 0.0260 -0.1460 0.0245 0.1889 0.0190 0.0801 0.1288 -0.2313* 
  0.2895 0.8018 0.1558 0.8131 0.0667 0.8549 0.4377 0.2111 0.0233 
Knowledge 0.0730 -0.4216*  0.0778 0.1853 -0.0540 -0.0829 0.0155 0.2538* 0.1105 
  0.5095 0.0000 0.4510 0.0706 0.6032 0.4247 0.8807 0.0126 0.2840 
Ease 0.0025 -0.1491 0.0168 -0.0243 -0.0541 -0.0353 -0.0109 -0.0626 -0.0456 
  0.9820 0.1470 0.8708 0.8139 0.6025 0.7339 0.9163 0.5446 0.6594 
Reality 0.2124 -0.1695 -0.1661 0.1315 0.3021* 0.0540 0.1091 0.0049 -0.0272 
  0.0539 0.1006 0.1077 0.2039 0.0031 0.6053 0.2924 0.9625 0.7936 
Similarity 0.0515 -0.0212 -0.1055 0.0839 0.1510 0.0010 0.1417 0.1103 0.0420 
  0.6457 0.8395 0.3117 0.4214 0.1486 0.9926 0.1731 0.2898 0.6881 
Engagement 0.0084 -0.0223 0.1089 -0.0061 0.0132 0.0938 0.0088 0.1700 0.0140 
  0.9397 0.8294 0.2907 0.9532 0.8989 0.3659 0.9324 0.0977 0.8925 





0.1923  0.4141 0.9462 0.3074 0.2375 0.5766 0.2690 0.6942 
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